{"meta":{"query_hash":"bc6c5d71f5d0","filters":{"venue":"Drugs of today"},"cohort_total":57,"direct_labels_cover":0,"predictions_cover":57,"exported":57,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/bc6c5d71f5d0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs+of+today"},"results":[{"id":"W183877133","doi":"10.1358/dot.2012.48.12.1885866","title":"Remestemcel-L, the first cellular therapy product for the treatmentof graft-versus-host disease","year":2012,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Mesenchymal stem cell; Graft-versus-host disease; Disease; Transplantation; Cell therapy; Front line; Stem cell; Immunology; Surgery; Internal medicine; Pathology","score_opus":0.07970850809014411,"score_gpt":0.3356937943612554,"score_spread":0.2559852862711113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W183877133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004095759,0.9891151,0.000046166635,0.0020112987,0.00086086843,0.0069893333,0.00019512771,0.0000438783,0.0006972705],"genre_scores_gemma":[0.0014392285,0.99372613,0.00007704672,0.000077184464,0.00073309726,0.0012417503,0.0003918117,0.00011358131,0.0022001902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978282,0.00013304452,0.00070948346,0.00043226095,0.0005021054,0.00039493843],"domain_scores_gemma":[0.99634224,0.00150853,0.0004788338,0.0013880034,0.00011934689,0.00016303509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073781185,0.00050757127,0.0012371526,0.00008611775,0.0002071712,0.000025245537,0.00043248903,0.000121718695,0.00011874709],"category_scores_gemma":[0.00006278074,0.00022794967,0.000979332,0.00023804298,0.00016790608,0.000057981895,0.000026702162,0.00022286766,0.00006268486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014987967,0.0009363322,0.00011042539,0.0850956,0.0033538484,0.000028653561,0.00298873,0.0000010365377,0.000018299299,0.0008300925,0.005000588,0.9001376],"study_design_scores_gemma":[0.0017018837,0.0001293346,0.00005622576,0.004994812,0.007617067,0.00001265594,0.00009281065,0.000003075107,0.00020041276,0.000007655456,0.98496425,0.00021983474],"about_ca_topic_score_codex":0.000035695117,"about_ca_topic_score_gemma":0.0000062515187,"teacher_disagreement_score":0.97996366,"about_ca_system_score_codex":0.00010431443,"about_ca_system_score_gemma":0.0003287047,"threshold_uncertainty_score":0.9295518},"labels":[],"label_agreement":null},{"id":"W1968779439","doi":"10.1358/dot.2005.41.4.908565","title":"Statin-associated neuromyotoxicity","year":2005,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Geranylgeranyl pyrophosphate; Myopathy; Rhabdomyolysis; Statin; Mevalonate pathway; Disease; Bioinformatics; Internal medicine; Prenylation; Biochemistry; Biology","score_opus":0.010485788395464093,"score_gpt":0.259453654406713,"score_spread":0.24896786601124887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968779439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98429143,0.00029583104,0.00005756308,0.0028736196,0.000067758534,0.00029597798,0.000013768445,0.00005528802,0.01204878],"genre_scores_gemma":[0.9965099,0.00005627337,0.0008568357,0.0012541418,0.00017986468,0.000008153416,0.000014579012,0.000015442249,0.001104808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99900305,0.000051948347,0.00022303264,0.00014501218,0.00038505846,0.00019191382],"domain_scores_gemma":[0.99936146,0.000025886993,0.00007986093,0.00032272204,0.0000958337,0.000114247974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043433555,0.00008347995,0.0002954575,0.000046731195,0.000033965338,0.0000041347753,0.00005921962,0.00005775137,0.000162804],"category_scores_gemma":[0.00013125794,0.00007009818,0.00019095531,0.00012584537,0.000030350671,0.0000454839,0.00002411394,0.00013278688,0.000040543768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043130765,0.002497696,0.02472533,0.0007753531,0.0012130127,0.0000861166,0.0046695205,0.00015346083,0.029923862,0.0020005754,0.045693267,0.8878305],"study_design_scores_gemma":[0.010136113,0.0010852912,0.46906304,0.00038830002,0.00045306975,0.00005817467,0.0005209312,0.0010020473,0.17197447,0.00028850426,0.34447032,0.0005597337],"about_ca_topic_score_codex":0.00021154097,"about_ca_topic_score_gemma":0.000015641304,"teacher_disagreement_score":0.88727075,"about_ca_system_score_codex":0.000056278663,"about_ca_system_score_gemma":0.00008972387,"threshold_uncertainty_score":0.28585204},"labels":[],"label_agreement":null},{"id":"W1988535187","doi":"10.1358/dot.2009.45.10.1417873","title":"Degarelix for the treatment of prostate cancer","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Testosterone (patch); Castration; Androgen deprivation therapy; Gonadotropin-releasing hormone; Hormone antagonist; Prostate; Management of prostate cancer; Orchiectomy; Hormone; Internal medicine; Urology; Oncology; Cancer; Endocrine system; Luteinizing hormone","score_opus":0.06837846130566895,"score_gpt":0.4177318112487104,"score_spread":0.34935334994304146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988535187","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003868321,0.99360377,0.0000014117801,0.000581275,0.00014768988,0.0043794736,0.00052559905,0.00001275048,0.00070932915],"genre_scores_gemma":[0.000035866266,0.98339236,0.00009053131,0.000017194365,0.00019006066,0.001242689,0.00020631817,0.000038901195,0.014786106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986842,0.00003421979,0.00047328224,0.0002556801,0.0002702891,0.00028232893],"domain_scores_gemma":[0.99863994,0.0003274191,0.0003215222,0.0004490557,0.00018379015,0.00007827404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013613445,0.0002911343,0.001538382,0.00012205708,0.000051097257,0.0000066290404,0.0001512187,0.0001329666,0.00006526964],"category_scores_gemma":[0.000018372612,0.00013090808,0.0007811742,0.000193671,0.00011983401,0.00001893867,0.000015074001,0.00009434287,0.000004931881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001941054,0.00033765438,0.0000159782,0.010170914,0.0008719741,0.000004360088,0.00045482937,5.5390456e-7,0.0000013069413,0.0000243462,0.0024520764,0.9854719],"study_design_scores_gemma":[0.001621443,0.0015567612,0.000014564173,0.007578826,0.0027527297,0.0000032550045,0.00004227091,0.000003053025,0.00026870734,0.000022659215,0.98603076,0.000104985855],"about_ca_topic_score_codex":0.00021256412,"about_ca_topic_score_gemma":0.000010193188,"teacher_disagreement_score":0.98536694,"about_ca_system_score_codex":0.00030673464,"about_ca_system_score_gemma":0.00083373167,"threshold_uncertainty_score":0.53382766},"labels":[],"label_agreement":null},{"id":"W1995684830","doi":"10.1358/dot.2006.42.3.957358","title":"Clinical experience with erlotinib in non-small-cell lung cancer(NSCLC)","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Epidermal growth factor receptor; Erlotinib Hydrochloride; Oncology; Tyrosine kinase; EGFR inhibitors; Cancer research; Cancer; T790M; Tyrosine-kinase inhibitor; Clinical trial; Internal medicine; Pharmacology; Gefitinib; Receptor","score_opus":0.03141548310013683,"score_gpt":0.41588384948687834,"score_spread":0.38446836638674153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995684830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022324114,0.9795076,0.000019695935,0.00005463032,0.00029546797,0.00191151,0.00008108901,0.000025045192,0.01587254],"genre_scores_gemma":[0.0013748163,0.990953,0.00088375725,0.000076551376,0.00025040534,0.00070166413,0.00016973427,0.00006649225,0.0055235783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979218,0.00006403841,0.00095226755,0.00050535816,0.00025735784,0.0002991466],"domain_scores_gemma":[0.9986116,0.00017963152,0.0004965313,0.0004896022,0.000091719376,0.00013090315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017002078,0.00035950975,0.0018165105,0.0001733919,0.000032866155,0.000011276633,0.00019366886,0.00023727813,0.0000884835],"category_scores_gemma":[0.000016682927,0.00023851822,0.0003606473,0.00036098715,0.00011167513,0.000046647427,0.000043764223,0.00036865805,0.000011768781],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054535914,0.00092535315,0.01695101,0.019699464,0.00042027506,0.00012951126,0.0015733782,0.000007215901,4.3454455e-7,0.000022605125,0.0032740925,0.95694214],"study_design_scores_gemma":[0.0031964874,0.0002817439,0.00173219,0.03975999,0.0034135014,0.000015142785,0.00020516998,0.000013077509,0.000008889143,0.0000015459151,0.95098203,0.00039021063],"about_ca_topic_score_codex":0.0015076566,"about_ca_topic_score_gemma":0.00019998603,"teacher_disagreement_score":0.9565519,"about_ca_system_score_codex":0.00025324847,"about_ca_system_score_gemma":0.0013005951,"threshold_uncertainty_score":0.97264904},"labels":[],"label_agreement":null},{"id":"W2002072862","doi":"10.1358/dot.2006.42.9.996568","title":"Ropinirole treatment for restless legs syndrome","year":2006,"lang":"en","type":"review","venue":"Drugs of today","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ropinirole; Restless legs syndrome; Medicine; Selegiline; Levodopa; Pramipexole; Placebo; Dopaminergic; Rotigotine; Population; Dopamine agonist; Dopamine; Pharmacology; Internal medicine; Parkinson's disease; Insomnia; Alternative medicine; Disease","score_opus":0.11435771493024179,"score_gpt":0.43399652833237107,"score_spread":0.3196388134021293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002072862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016554644,0.9876613,0.000019975862,0.0001963191,0.00022695443,0.003924278,0.00042186346,0.00006784197,0.007315936],"genre_scores_gemma":[0.00013047131,0.9664648,0.0006552892,0.000008333403,0.0002422559,0.0009950162,0.000996645,0.00019340684,0.03031376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99662477,0.00014296918,0.001096216,0.0007295892,0.0007120933,0.0006943684],"domain_scores_gemma":[0.99726367,0.0005636702,0.00046760842,0.0012566379,0.00018726577,0.00026113985],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039501672,0.00064141303,0.00397021,0.000621743,0.000071588605,0.000031265834,0.00042616835,0.00055048324,0.00012472575],"category_scores_gemma":[0.00010245124,0.0004580382,0.0015452054,0.00040562404,0.00016722351,0.0000617534,0.000106699576,0.000345139,0.00020493078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052418716,0.000641049,0.00001736262,0.0646839,0.00076188555,0.00029412104,0.000040133607,0.0000013323772,0.0000028546267,0.00033420592,0.007405532,0.9257652],"study_design_scores_gemma":[0.0013558797,0.0010222021,0.000040173345,0.017566988,0.0013091455,0.0005810712,0.0000120041705,0.0000053156605,0.00002124544,0.00004147993,0.9777064,0.0003381516],"about_ca_topic_score_codex":0.0002997629,"about_ca_topic_score_gemma":0.0000068522227,"teacher_disagreement_score":0.9703008,"about_ca_system_score_codex":0.00065109564,"about_ca_system_score_gemma":0.0011171805,"threshold_uncertainty_score":0.99978715},"labels":[],"label_agreement":null},{"id":"W2003316205","doi":"10.1358/dot.2010.46.2.1464700","title":"Saxagliptin in type 2 diabetes","year":2010,"lang":"en","type":"article","venue":"Drugs of today","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Saxagliptin; Medicine; Glycemic; Metformin; Incretin; Type 2 diabetes; Hypoglycemia; Pharmacology; Diabetes mellitus; Internal medicine; Sitagliptin; Endocrinology","score_opus":0.006862667400269849,"score_gpt":0.24396767172015393,"score_spread":0.23710500431988407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003316205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491215,0.000115938295,2.2035707e-7,0.00082508987,0.0002811375,0.00015618121,0.0000013984287,0.000021499905,0.049477078],"genre_scores_gemma":[0.995718,0.00001809342,0.0006059244,0.00021167274,0.000050866936,0.0000069853786,0.000016795188,0.0000089104215,0.0033627339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952656,0.0000058617215,0.00012016893,0.000102176775,0.00010178771,0.00014346161],"domain_scores_gemma":[0.9996748,0.000028744804,0.00003262871,0.00019326895,0.000028111124,0.00004242786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012378037,0.00006582162,0.00016152648,0.000096950105,0.000007406645,0.0000039937263,0.00005392154,0.000036573205,0.00034847116],"category_scores_gemma":[0.000049000046,0.00005329637,0.00003745077,0.0001226354,0.000030126439,0.000034821667,0.000032002717,0.0000840691,0.000090158224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010840092,0.0013090392,0.6694132,0.0002618561,0.00022549849,0.000023929902,0.001116966,0.0000030360025,0.10048496,0.009369389,0.023649078,0.19403462],"study_design_scores_gemma":[0.0046015778,0.0007077043,0.6036561,0.000223317,0.00022621204,6.0552685e-7,0.00026026,0.00021988303,0.14024293,0.0010477203,0.2485027,0.00031096494],"about_ca_topic_score_codex":0.000021267186,"about_ca_topic_score_gemma":0.000019045163,"teacher_disagreement_score":0.22485362,"about_ca_system_score_codex":0.000010162039,"about_ca_system_score_gemma":0.000015195198,"threshold_uncertainty_score":0.38155147},"labels":[],"label_agreement":null},{"id":"W2020779524","doi":"10.1358/dot.2004.40.10.863742","title":"Gefitinib: Current status in the treatment of non-small cell lungcancer","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Internal medicine; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Adverse effect","score_opus":0.03334470967723603,"score_gpt":0.38308849286908947,"score_spread":0.34974378319185345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020779524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006766252,0.9906311,0.000003994742,0.00004864819,0.00028410016,0.0021118552,0.00037627842,0.000008394004,0.0058589736],"genre_scores_gemma":[0.0010800307,0.9971522,0.00020378822,0.000015738558,0.00011565792,0.00046723947,0.00039420705,0.00003657075,0.00053457415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984857,0.000055414937,0.0006478372,0.00028283018,0.00025028083,0.00027797904],"domain_scores_gemma":[0.99878484,0.00014476293,0.0004278536,0.00049708673,0.00006901331,0.00007642859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085756204,0.0003341268,0.0013886892,0.00018408468,0.000023720166,0.0000064901424,0.00013726852,0.00010982539,0.00007013006],"category_scores_gemma":[0.0000064776154,0.00017972324,0.00054647395,0.00027286072,0.00005949388,0.000020932916,0.0000140242,0.00014456957,0.00001724284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015322761,0.0019097885,0.00014373744,0.018099274,0.00026744764,0.000015095274,0.004389139,0.0000053472613,3.9850497e-7,0.0000494127,0.00020757456,0.97489744],"study_design_scores_gemma":[0.0022972538,0.00060460967,0.00024945152,0.014651472,0.0033142192,0.0000044450585,0.00021458224,6.5006276e-7,0.00002644151,0.000015848476,0.97848153,0.00013951483],"about_ca_topic_score_codex":0.0010850321,"about_ca_topic_score_gemma":0.000063449275,"teacher_disagreement_score":0.9782739,"about_ca_system_score_codex":0.0007666033,"about_ca_system_score_gemma":0.0014510575,"threshold_uncertainty_score":0.73289007},"labels":[],"label_agreement":null},{"id":"W2029669980","doi":"10.1358/dot.2009.45.1.1315920","title":"Strategies to preserve prostate health","year":2009,"lang":"en","type":"review","venue":"Drugs of today","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital","funders":"","keywords":"Medicine; Prostate cancer; Prostatitis; Prostate Diseases; Clinical trial; Prostate; Etiology; Prostate disease; Intensive care medicine; Bioinformatics; Cancer; Pathology; Internal medicine","score_opus":0.045376115858439495,"score_gpt":0.3922815173844368,"score_spread":0.3469054015259973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029669980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012208708,0.9887825,0.0000026286302,0.002146211,0.00012388329,0.003136601,0.00026982254,0.00004682116,0.0054793134],"genre_scores_gemma":[0.000048419137,0.99684227,0.0005326869,0.00040541674,0.00011565691,0.0003670503,0.0003417229,0.0000461603,0.0013006456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808806,0.00007313615,0.00071773736,0.0004289437,0.0003129998,0.0003791151],"domain_scores_gemma":[0.9985485,0.00006905199,0.00039695413,0.00058139494,0.00009738041,0.00030671473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023664968,0.00037963883,0.002263632,0.00018429077,0.00003660319,0.00003008264,0.00016462237,0.00011473154,0.000057602967],"category_scores_gemma":[0.000020764071,0.00026284452,0.0004330917,0.00026987525,0.000031196123,0.00006774324,0.0000618722,0.00020492764,0.00006782433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020159916,0.00023541781,0.0000053382096,0.022733673,0.00021456796,0.000021268968,0.00047445679,0.0000011849032,6.546752e-8,0.0003300756,0.022909049,0.9530547],"study_design_scores_gemma":[0.00038895852,0.001292648,0.000050146264,0.032565393,0.00040609454,0.000010593576,0.00009754907,1.7731233e-7,0.000009801858,0.00009886451,0.9649043,0.00017547142],"about_ca_topic_score_codex":0.00020469746,"about_ca_topic_score_gemma":0.00001336268,"teacher_disagreement_score":0.95287925,"about_ca_system_score_codex":0.00033548663,"about_ca_system_score_gemma":0.001556202,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W2038264909","doi":"10.1358/dot.2003.39.8.799407","title":"Role of 5-HT receptors in treatment of overactive bladder","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Serotonergic; Overactive bladder; Urination; Reflex; Duloxetine; Urology; Urinary bladder; Urethral sphincter; Receptor; Internal medicine; Endocrinology; Pharmacology; Serotonin; Urethra; Urinary system; Pathology","score_opus":0.040580010735959814,"score_gpt":0.37369519770281967,"score_spread":0.3331151869668599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038264909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006802391,0.9696228,1.7724162e-7,0.00002184582,0.000069740716,0.0011914158,0.00012508962,0.0000047397452,0.028283961],"genre_scores_gemma":[0.00064606185,0.9954362,0.00012638602,0.0000033836795,0.000038388283,0.000064586435,0.00013320922,0.00004081614,0.00351096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998007,0.00023956316,0.0007881251,0.00029098915,0.0004105651,0.00026377692],"domain_scores_gemma":[0.9985603,0.0003441092,0.00040641698,0.00045253485,0.00013756256,0.0000990464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026804573,0.00029415337,0.0022351267,0.00045393786,0.0000105894605,0.0000021310696,0.00011730948,0.00023174519,0.00081481657],"category_scores_gemma":[0.000053462078,0.00021167002,0.00052592234,0.0004223562,0.0001113989,0.000044582288,0.000035236913,0.00022595718,0.00001916035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015895473,0.0014254394,0.00016272729,0.009529376,0.000718471,0.000015079427,0.0014724832,4.4043296e-7,0.0000309958,0.000045769415,0.0004235713,0.9860167],"study_design_scores_gemma":[0.0010494096,0.0015575158,0.00006002096,0.005493904,0.000575858,0.000016453698,0.00039257613,8.189283e-7,0.0012859632,0.00005208557,0.9893666,0.00014882386],"about_ca_topic_score_codex":0.00031326775,"about_ca_topic_score_gemma":0.0000054148186,"teacher_disagreement_score":0.988943,"about_ca_system_score_codex":0.00020046103,"about_ca_system_score_gemma":0.0006639599,"threshold_uncertainty_score":0.892167},"labels":[],"label_agreement":null},{"id":"W2041935038","doi":"10.1358/dot.2008.44.7.1227147","title":"Desvenlafaxine succinate for major depressive disorder","year":2008,"lang":"en","type":"review","venue":"Drugs of today","topic":"Treatment of Major Depression","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Venlafaxine; Internal medicine; Adverse effect; Pharmacology; Antidepressant; Vasomotor; Endocrinology","score_opus":0.027669575657758242,"score_gpt":0.3371435443253235,"score_spread":0.30947396866756527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041935038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009237764,0.9938908,0.00008622305,0.00015164835,0.0002988205,0.0031428256,0.00028214083,0.0000937667,0.001961373],"genre_scores_gemma":[0.00012310728,0.98888326,0.0019799613,0.000033140946,0.00025042277,0.0006287337,0.00085316855,0.00017095482,0.0070772353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756604,0.000082862985,0.00084346137,0.00063749246,0.0004369151,0.00043323872],"domain_scores_gemma":[0.9974935,0.0005040723,0.0007274382,0.00089744944,0.00018404162,0.00019349859],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000114516224,0.0006331255,0.002805012,0.00032989486,0.000105443294,0.000009225957,0.00031040944,0.00047473845,0.00015557464],"category_scores_gemma":[0.00024190286,0.00043749678,0.0012790515,0.00022242033,0.00010081624,0.00007731751,0.00013641847,0.00031400038,0.00007671224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010465076,0.000459174,0.00009323088,0.020307168,0.0006728055,0.000062359446,0.0000743752,4.7574196e-7,0.0000029206547,0.000047804588,0.010704568,0.96747047],"study_design_scores_gemma":[0.0034002257,0.00029119977,0.00007849506,0.01778165,0.0028077732,0.00018139096,0.000009603959,0.0000029034927,0.0001125294,0.000046130503,0.9749373,0.00035077345],"about_ca_topic_score_codex":0.00004374726,"about_ca_topic_score_gemma":0.0000031818063,"teacher_disagreement_score":0.9671197,"about_ca_system_score_codex":0.00013189117,"about_ca_system_score_gemma":0.00029962827,"threshold_uncertainty_score":0.99980766},"labels":[],"label_agreement":null},{"id":"W2045159955","doi":"10.1358/dot.2004.40.5.850489","title":"Levocetirizine: A new selective H1 receptor antagonist for use inallergic disorders","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Levocetirizine; Cetirizine; Medicine; Pharmacology; Histamine; Histamine H1 receptor; Antagonist; Pharmacokinetics; Receptor; Internal medicine","score_opus":0.03495536806048386,"score_gpt":0.3191909200766362,"score_spread":0.2842355520161523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045159955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041604533,0.99296075,0.0008766622,0.00053867756,0.00045702694,0.002568961,0.00018429053,0.0000764157,0.002295612],"genre_scores_gemma":[0.00007311561,0.9851433,0.004450268,0.00010419667,0.00038823034,0.00006468762,0.0016209999,0.0001218063,0.008033367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997956,0.000066273344,0.00079099264,0.000517684,0.00032847657,0.0003406118],"domain_scores_gemma":[0.99834514,0.00025615978,0.00057648827,0.00038319567,0.00024155017,0.00019749098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016648092,0.00047633404,0.0019882815,0.00024052027,0.00009288157,0.000034399563,0.00015290367,0.00041092822,0.00011969443],"category_scores_gemma":[0.00027508978,0.0003909035,0.0007974714,0.00039592502,0.000095056545,0.0001114547,0.000042750144,0.00032845757,0.00004116288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021362478,0.00027462348,0.000007051219,0.019765405,0.0007705464,0.000008240605,0.0007084369,0.0000062637187,0.0000053537333,0.0012509461,0.04718941,0.9298001],"study_design_scores_gemma":[0.0015900279,0.00037395587,0.000008594276,0.01428461,0.00081087206,0.000033128552,0.00006629566,0.000011973031,0.000011795781,0.0001824264,0.98226476,0.00036158125],"about_ca_topic_score_codex":0.00025260155,"about_ca_topic_score_gemma":0.000030819003,"teacher_disagreement_score":0.93507534,"about_ca_system_score_codex":0.00029065646,"about_ca_system_score_gemma":0.0014630588,"threshold_uncertainty_score":0.99985427},"labels":[],"label_agreement":null},{"id":"W2053823757","doi":"10.1358/dot.2002.38.10.740195","title":"Identification of parkinsonism and Parkinson's disease","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Glenrose Rehabilitation Hospital","funders":"","keywords":"Parkinsonism; Medicine; Progressive supranuclear palsy; Parkinson's disease; Disease; Magnetic resonance imaging; Neuroimaging; Dopaminergic; Movement disorders; Physical medicine and rehabilitation; Psychiatry; Pathology; Radiology; Internal medicine; Dopamine","score_opus":0.027922660074428625,"score_gpt":0.3044069923022708,"score_spread":0.2764843322278422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053823757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007397283,0.99695593,0.000016320993,0.00004427178,0.0001670408,0.0009651083,0.00054092053,0.00003177524,0.00053889723],"genre_scores_gemma":[0.021153705,0.9769649,0.00014144674,0.000019155525,0.000076459335,0.00012430838,0.00021767568,0.00006100464,0.0012413574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978319,0.00010127784,0.0008589469,0.000535931,0.00043840808,0.00023353449],"domain_scores_gemma":[0.9978814,0.00009484896,0.00085695606,0.00070384535,0.00009997573,0.0003629323],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021929681,0.00040650007,0.0017254135,0.00030201435,0.000047096877,0.000015040204,0.00015625599,0.00019464249,0.00012028214],"category_scores_gemma":[0.00008938729,0.00032618144,0.0005820515,0.00022180635,0.0001203391,0.00006642741,0.0000756005,0.0001508927,0.000042998905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037966423,0.0005265848,0.000106669366,0.022235347,0.0004704024,0.00005517543,0.00006851302,7.78496e-8,0.0000053749422,0.0002845305,0.00046029824,0.9757491],"study_design_scores_gemma":[0.000692314,0.00007079964,0.00084565446,0.007422506,0.0044743,0.000013292465,0.0000123110285,0.000017635313,0.000053231473,0.00016407161,0.98601204,0.00022184255],"about_ca_topic_score_codex":0.000013052278,"about_ca_topic_score_gemma":3.0981494e-7,"teacher_disagreement_score":0.9855517,"about_ca_system_score_codex":0.000067256784,"about_ca_system_score_gemma":0.00017366622,"threshold_uncertainty_score":0.999919},"labels":[],"label_agreement":null},{"id":"W2064695702","doi":"10.1358/dot.2002.38.1.677133","title":"Medical backgrounder on varicocele","year":2002,"lang":"en","type":"review","venue":"Drugs of today","topic":"Sperm and Testicular Function","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Varicocele; Medicine; Hydrocele; Male infertility; Semen quality; Infertility; Urology; Semen; Surgery; Andrology; Pregnancy; Biology","score_opus":0.05104752085932522,"score_gpt":0.329940138467689,"score_spread":0.27889261760836376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064695702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000065932195,0.9409012,0.000035501693,0.00015989701,0.0005298709,0.00034077102,0.000006881522,0.000050311734,0.057968963],"genre_scores_gemma":[0.000065927095,0.9935886,0.000100914614,0.00027498094,0.00054988265,0.000021556934,0.00011959715,0.000049010316,0.0052295215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824417,0.00006130746,0.00045924901,0.00030229444,0.0007382557,0.00019471024],"domain_scores_gemma":[0.99882925,0.00029035532,0.00018454458,0.00044217636,0.000061224455,0.00019243373],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00024078153,0.00026562443,0.001300873,0.00017490162,0.000025432299,0.000006829311,0.00013461299,0.0004692805,0.006061676],"category_scores_gemma":[0.0003540792,0.00018136675,0.0005031783,0.0002321151,0.000062244595,0.000026281,0.00003722797,0.00047596023,0.0010660773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056622303,0.00030370586,0.0000031580823,0.007469855,0.00017238472,0.000064826825,0.00001938067,4.291631e-8,9.011974e-8,0.0009132033,0.016154543,0.97489315],"study_design_scores_gemma":[0.00037864383,0.00019784676,0.000010305666,0.012977953,0.0009912914,0.00016773869,0.000006865404,0.000012998362,0.0000012627121,0.000030059718,0.98507637,0.00014868593],"about_ca_topic_score_codex":0.00001643756,"about_ca_topic_score_gemma":3.8402786e-7,"teacher_disagreement_score":0.97474444,"about_ca_system_score_codex":0.00009390308,"about_ca_system_score_gemma":0.00020556276,"threshold_uncertainty_score":0.9997117},"labels":[],"label_agreement":null},{"id":"W2079795343","doi":"10.1358/dot.2011.47.5.1584113","title":"Psychosis in Parkinson's disease: Therapeutic options","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Quetiapine; Ziprasidone; Medicine; Psychosis; Clozapine; Olanzapine; Risperidone; Rivastigmine; Parkinson's disease; Psychiatry; Donepezil; Antipsychotic; Amantadine; Amisulpride; Disease; Schizophrenia (object-oriented programming); Intensive care medicine; Dementia; Pharmacology; Internal medicine","score_opus":0.051478196202870315,"score_gpt":0.3382877219087331,"score_spread":0.28680952570586277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079795343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007907385,0.9954528,0.0000100979805,0.00005650843,0.00025441722,0.0011390516,0.0002713405,0.00004620956,0.0026904999],"genre_scores_gemma":[0.0026793904,0.9950251,0.00026716632,0.000081341335,0.00008015119,0.0005001246,0.00026793385,0.00008210264,0.0010167126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981649,0.00012502461,0.00056451646,0.0005381707,0.00026932269,0.00033805185],"domain_scores_gemma":[0.9984533,0.000063440195,0.00030831958,0.0007786358,0.000048544138,0.0003477194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015970923,0.0004601882,0.0016193307,0.00043676258,0.000037316375,0.0000103505,0.00023169412,0.0002164356,0.00044329124],"category_scores_gemma":[0.000020536689,0.00034904914,0.0008448406,0.00037249818,0.000060681075,0.0000546153,0.00005227118,0.0002498816,0.00017740641],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006320487,0.0011118797,0.00044753877,0.0071125417,0.00054774765,0.000071803974,0.000070454946,6.617837e-8,1.8373046e-7,0.0011456622,0.00048759487,0.9889413],"study_design_scores_gemma":[0.00074858393,0.00007391976,0.0022172136,0.011466091,0.0030431994,0.0000070212345,0.000012242166,0.0000018977534,0.0000014118096,0.00041383365,0.981759,0.0002555955],"about_ca_topic_score_codex":0.0000641006,"about_ca_topic_score_gemma":0.000004516902,"teacher_disagreement_score":0.9886857,"about_ca_system_score_codex":0.00013925272,"about_ca_system_score_gemma":0.00029164678,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W2117178293","doi":"10.1358/dot.2004.40.11.872578","title":"Efalizumab: Advancing psoriasis management with a novel, targetedT-cell modulator","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Psoriasis; Medicine; Pathogenesis; Monoclonal antibody; Immunology; Clinical trial; Monoclonal; Dermatology; Antibody; Plaque psoriasis; Pathology","score_opus":0.013235696228063943,"score_gpt":0.24904233892696076,"score_spread":0.2358066426988968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117178293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015855882,0.9925759,0.0001360633,0.00001135569,0.0009832344,0.001147415,0.0007360142,0.00010397591,0.0041474937],"genre_scores_gemma":[0.0005797456,0.99074477,0.002013124,0.000017220884,0.00006781987,0.0002566464,0.00087279966,0.00011931345,0.0053285374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975169,0.00014794002,0.0007749234,0.00076652714,0.0001421217,0.0006515971],"domain_scores_gemma":[0.9981795,0.00012973252,0.00070724543,0.00082861795,0.00009950004,0.000055433597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003006564,0.0007923865,0.0021128822,0.00039836287,0.00014619372,0.000014998725,0.0005578967,0.0005957403,0.00034455617],"category_scores_gemma":[0.000013284327,0.0005777818,0.0006787325,0.0003967317,0.00012555801,0.000091618014,0.00016618421,0.0002949635,0.0003024563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012549796,0.00066063984,0.000004567117,0.019140149,0.0032565894,0.000043279724,0.00025944033,0.00002053885,0.000096284115,0.0006294167,0.001050805,0.9747128],"study_design_scores_gemma":[0.0029380142,0.00020247723,0.0000053862395,0.0097890375,0.004191254,0.00005151217,0.000090691705,1.3451779e-7,0.000980658,0.000025872805,0.9810862,0.0006387805],"about_ca_topic_score_codex":0.00008005888,"about_ca_topic_score_gemma":0.000007887474,"teacher_disagreement_score":0.98003536,"about_ca_system_score_codex":0.0003479577,"about_ca_system_score_gemma":0.0003158697,"threshold_uncertainty_score":0.99966735},"labels":[],"label_agreement":null},{"id":"W2317463698","doi":"10.1358/dot.2000.36.2-3.568786","title":"Sildenafil citrate (Viagra(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Sildenafil; Medicine; Cyclic guanosine monophosphate; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Pharmacology; Erectile function; Phosphodiesterase; Phosphodiesterase inhibitor; Internal medicine; Urology; Biochemistry; Enzyme","score_opus":0.013805522544178545,"score_gpt":0.2656979121947541,"score_spread":0.25189238965057553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317463698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60925543,0.0004432493,0.000036566813,0.0020156563,0.00034127056,0.00013183065,0.0000052750484,0.000109887085,0.38766083],"genre_scores_gemma":[0.86569154,0.00015553166,0.00018044711,0.0020179034,0.0001773427,0.000008334574,0.000010729394,0.000011765929,0.13174641],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992852,0.000015139928,0.00020058501,0.00015103167,0.0002130201,0.00013499842],"domain_scores_gemma":[0.9995572,0.00004526323,0.00003543841,0.00019541873,0.000085391126,0.00008127366],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001036276,0.0000929122,0.00022013627,0.000063749096,0.00005230112,0.0000051871084,0.000035867917,0.000046039702,0.0087816715],"category_scores_gemma":[0.0000359408,0.00007260166,0.000086109496,0.000171856,0.0000627429,0.000043959768,0.000010138066,0.0000856592,0.00086896436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023511352,0.0009656468,0.033387158,0.00023891631,0.00063393294,0.000046276426,0.003997969,0.00007550883,0.015193322,0.0032753146,0.5650018,0.37483302],"study_design_scores_gemma":[0.0024834604,0.00041057897,0.05222521,0.00005693719,0.00011173457,0.000033882927,0.001028845,0.000052365205,0.010037121,0.00024836836,0.933134,0.00017746448],"about_ca_topic_score_codex":0.000054657357,"about_ca_topic_score_gemma":0.0000015972753,"teacher_disagreement_score":0.37465554,"about_ca_system_score_codex":0.000014108659,"about_ca_system_score_gemma":0.000025319661,"threshold_uncertainty_score":0.999909},"labels":[],"label_agreement":null},{"id":"W2321447119","doi":"10.1358/dot.2011.47.6.1603439","title":"Tesamorelin: A novel therapeutic option for HIV/HAART-associatedincreased visceral adipose tissue","year":2011,"lang":"en","type":"article","venue":"Drugs of today","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Adipose tissue; Hormone; Glucose homeostasis; Endocrinology; Internal medicine; Homeostasis; Lipid profile; Obesity; Bioinformatics; Diabetes mellitus; Insulin resistance; Biology","score_opus":0.037363104453776066,"score_gpt":0.3154414242656713,"score_spread":0.27807831981189524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321447119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467995,0.0018402897,0.010975034,0.007730434,0.00044176524,0.0046761315,0.0005356911,0.0003412403,0.026659898],"genre_scores_gemma":[0.98724496,0.000041028325,0.009729998,0.00044798115,0.00007548051,0.00016242103,0.00022380135,0.00003126903,0.002043041],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99899125,0.000019069459,0.00034845536,0.00022586384,0.00015717228,0.0002581984],"domain_scores_gemma":[0.9990627,0.00009138732,0.00017504508,0.0002978319,0.00022154824,0.00015148908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018461616,0.00013585525,0.00029258855,0.00010892891,0.00010056044,0.000004710822,0.00008540372,0.0001302198,0.00017110606],"category_scores_gemma":[0.000044818735,0.00011895258,0.00010336145,0.0001396727,0.000040858744,0.000054405424,0.000014723174,0.00010774501,0.00011411812],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011920927,0.038330507,0.16976981,0.0028018863,0.0068589128,0.00006141945,0.041448947,0.000053866166,0.18764041,0.0794993,0.046999145,0.4146149],"study_design_scores_gemma":[0.04526211,0.0065189307,0.7955425,0.0015789606,0.003682411,0.000102931386,0.0009519853,0.011329008,0.042657387,0.0071258517,0.08403126,0.0012166804],"about_ca_topic_score_codex":0.0002837771,"about_ca_topic_score_gemma":0.000005491786,"teacher_disagreement_score":0.62577266,"about_ca_system_score_codex":0.0000987584,"about_ca_system_score_gemma":0.00010678102,"threshold_uncertainty_score":0.48507455},"labels":[],"label_agreement":null},{"id":"W2325941892","doi":"10.1358/dot.2000.36.2-3.568785","title":"Oral phentolamine (Vasomax(R))","year":2000,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre","funders":"","keywords":"Phentolamine; Medicine; Sympatholytic; Anesthesia; Internal medicine; Blood pressure; Propranolol","score_opus":0.011429716263223588,"score_gpt":0.26645212058433,"score_spread":0.2550224043211064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325941892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86333156,0.0011472737,0.0000014448102,0.0024227856,0.0000642848,0.00010563716,0.000004526178,0.000027644901,0.13289486],"genre_scores_gemma":[0.9654157,0.00018117623,0.0003558666,0.00011774797,0.00018878857,0.000004422758,0.0000061124338,0.0000081614035,0.033721995],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999365,0.000011004079,0.00014485292,0.00016359218,0.00018259486,0.00013295472],"domain_scores_gemma":[0.9996614,0.000015323922,0.000024961068,0.0001816933,0.00006878969,0.00004786764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000964043,0.00008103859,0.0002479229,0.00003525942,0.000032220225,0.0000018340415,0.00004602433,0.000025755739,0.0010090807],"category_scores_gemma":[0.00003072814,0.000054752996,0.00008190409,0.00011056496,0.00010685293,0.000032995275,0.000018764167,0.00006630081,0.0001607996],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010703941,0.0013658593,0.036908343,0.00031266085,0.000753385,0.00007844807,0.0069745188,0.000011578639,0.04057062,0.0013566327,0.021532595,0.88906497],"study_design_scores_gemma":[0.0030983035,0.0007590342,0.49304792,0.00015537432,0.0002389232,0.00004453313,0.0013849468,0.000029189598,0.06700711,0.0010328628,0.43288267,0.0003191567],"about_ca_topic_score_codex":0.000050438564,"about_ca_topic_score_gemma":0.000001994227,"teacher_disagreement_score":0.8887458,"about_ca_system_score_codex":0.000012074817,"about_ca_system_score_gemma":0.000016341704,"threshold_uncertainty_score":0.99990416},"labels":[],"label_agreement":null},{"id":"W2327987781","doi":"10.1358/dot.2014.50.1.2118308","title":"A report from the 16th IGPA conference (December 9-11, 2013 -Brussels, Belgium)","year":2014,"lang":"en","type":"article","venue":"Drugs of today","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alliance; Medicine; Negotiation; Member states; Economic growth; International trade; Political science; Business; Law","score_opus":0.042667258274655735,"score_gpt":0.26738202488049334,"score_spread":0.2247147666058376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327987781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69178915,0.0013265917,0.001135095,0.03353388,0.0012705021,0.00031480586,0.0006638777,0.000051093502,0.26991498],"genre_scores_gemma":[0.9937638,0.0003209885,0.00031764133,0.0030067163,0.00038524315,0.00001796096,0.00004561506,0.000025883817,0.0021161612],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983769,0.00002824924,0.00081064436,0.00041420365,0.000044163062,0.0003258338],"domain_scores_gemma":[0.99826807,0.00028789707,0.00053068966,0.0007280341,0.000043551223,0.00014174456],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00083405105,0.0001803581,0.00047522993,0.00006560413,0.00008830991,0.00007574691,0.00053258083,0.00010991014,0.0020339426],"category_scores_gemma":[0.00020013606,0.00016011426,0.00017301069,0.0001076208,0.00013451192,0.00015800798,0.00014810357,0.00017823525,0.0010583925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002934696,0.00016408258,0.052651666,0.000026870906,0.00016479257,0.000005231296,0.0011917518,0.000103426944,0.00010253226,0.6882652,0.253209,0.004086115],"study_design_scores_gemma":[0.00046526073,0.0000151640015,0.014428478,0.0000135897135,0.000011879512,0.0000040171835,0.000029781211,0.004414522,0.00046227715,0.08874575,0.8911743,0.00023495493],"about_ca_topic_score_codex":0.0041257003,"about_ca_topic_score_gemma":0.00030527695,"teacher_disagreement_score":0.6379653,"about_ca_system_score_codex":0.000037129426,"about_ca_system_score_gemma":0.00003653784,"threshold_uncertainty_score":0.9997194},"labels":[],"label_agreement":null},{"id":"W2334764107","doi":"10.1358/dot.2013.49.9.2056599","title":"A report from the European Society of Cardiology Congress 2013(August 31-September 4, 2013 - Amsterdam, The Netherlands)","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Attendance; Session (web analytics); Canadian Cardiovascular Society; Convention; Alternative medicine; Medical education; Preclinical research; Family medicine; Medical physics; Internal medicine; Myocardial infarction; Pathology; Law; Political science","score_opus":0.011105435313271867,"score_gpt":0.23600798532777226,"score_spread":0.22490255001450038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334764107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93495476,0.0048522404,0.000112775655,0.0054946733,0.00041799,0.0007781838,0.00007231227,0.000038523678,0.053278524],"genre_scores_gemma":[0.99223137,0.00034106092,0.00008574301,0.00065067277,0.000742549,0.00002167678,0.00009946018,0.000029297313,0.0057981825],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99848104,0.00033650376,0.00039590386,0.00026315774,0.00031196335,0.00021141417],"domain_scores_gemma":[0.9981497,0.0002086303,0.00022469545,0.0011518106,0.00016642254,0.00009874759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073226093,0.0001645061,0.0005156942,0.0000135443615,0.00007685689,0.00001660771,0.00027829592,0.00008560072,0.0002802535],"category_scores_gemma":[0.000031026855,0.000085910026,0.00093635166,0.0000845606,0.00033003057,0.000062822786,0.00018374823,0.00023685956,0.00011852029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003707258,0.0000414168,0.05157461,0.00004215707,0.0019745727,0.000041781885,0.00052744674,0.000041910276,0.002309283,0.000005717495,0.9408664,0.002537599],"study_design_scores_gemma":[0.0017036747,0.000050367635,0.6916355,0.00014994705,0.0013655478,0.00014769175,0.00093675766,0.00009370142,0.0019167493,0.00010919127,0.3017009,0.0001899963],"about_ca_topic_score_codex":0.0017897879,"about_ca_topic_score_gemma":0.000009777709,"teacher_disagreement_score":0.64006084,"about_ca_system_score_codex":0.000010700518,"about_ca_system_score_gemma":0.000050500093,"threshold_uncertainty_score":0.3503309},"labels":[],"label_agreement":null},{"id":"W2339145532","doi":"10.1358/dot.2015.51.10.2401004","title":"Tavaborole topical solution, 5% for the treatment of toenailonychomycosis","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Trichophyton rubrum; Erythema; Nail (fastener); Clinical trial; Adverse effect; Antifungal; Dermatophyte; Internal medicine","score_opus":0.06903558764533257,"score_gpt":0.3846905140682847,"score_spread":0.3156549264229521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339145532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035869332,0.9965391,0.000025080653,0.00021287643,0.0002036656,0.0018643719,0.00047308885,0.000012377529,0.00063354237],"genre_scores_gemma":[0.00018968992,0.996215,0.0003140771,0.000016660773,0.00021618152,0.00039008114,0.00026104852,0.000028772276,0.0023685282],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988729,0.00003432176,0.00046087627,0.00021918396,0.00023376939,0.00017897408],"domain_scores_gemma":[0.9986575,0.00023452996,0.00027999075,0.0005270483,0.0001781288,0.0001227949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080402904,0.0002510258,0.0014211597,0.000064626394,0.00003658237,0.000004548027,0.00012082978,0.00013334758,0.00006416398],"category_scores_gemma":[0.00003793908,0.00012621688,0.0009804105,0.00011187048,0.000069244816,0.000017635188,0.000018326125,0.000043063268,0.000016691683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007703307,0.0010010022,0.0000530955,0.003835644,0.0010395877,0.0000023621897,0.00009186474,8.196997e-8,1.477933e-7,0.00012217426,0.006525305,0.9872517],"study_design_scores_gemma":[0.0015162815,0.001049073,0.00005949331,0.0018308487,0.006863755,0.000004501622,0.000019938409,0.000005748107,0.000008413578,0.00005340882,0.9885007,0.000087842534],"about_ca_topic_score_codex":0.000100016085,"about_ca_topic_score_gemma":0.000003554606,"teacher_disagreement_score":0.98716384,"about_ca_system_score_codex":0.00018388547,"about_ca_system_score_gemma":0.00035352708,"threshold_uncertainty_score":0.5146975},"labels":[],"label_agreement":null},{"id":"W2376717750","doi":"10.1358/dot.2013.49.12.2067249","title":"Simeprevir for the treatment of genotype 1 chronic hepatitis Cvirus","year":2013,"lang":"en","type":"article","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Simeprevir; Ribavirin; Medicine; Pegylated interferon; Virology; Hepatitis C virus; Genotype; Protease inhibitor (pharmacology); Interferon; Internal medicine; Pharmacology; Virus; Viral load; Biology","score_opus":0.027085152691921924,"score_gpt":0.3213115087311132,"score_spread":0.2942263560391913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2376717750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780219,0.008670502,0.00020559586,0.0026333658,0.00015336403,0.0032008693,0.0001101955,0.000028335371,0.0069758585],"genre_scores_gemma":[0.98870087,0.0060235183,0.000606888,0.00007436613,0.00017194524,0.00035338802,0.000020040827,0.000024859011,0.0040241326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900395,0.000035057987,0.00028565046,0.00015636974,0.00027398427,0.00024501793],"domain_scores_gemma":[0.99870783,0.00040765616,0.00008794542,0.00048638796,0.00022764939,0.00008250099],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014168235,0.00011093028,0.00032281125,0.000064106214,0.000046673813,0.000007171642,0.00013935212,0.000059518836,0.0014875676],"category_scores_gemma":[0.000108057415,0.000067370325,0.00017278425,0.00011467639,0.0001288266,0.000050238523,0.000024721785,0.000053589672,0.00018371698],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105650455,0.00042502413,0.019325232,0.0002759616,0.0003741362,0.0000025001982,0.0010596808,0.000016991517,0.021255512,0.00037466257,0.008030368,0.9487543],"study_design_scores_gemma":[0.003957648,0.0050908905,0.06689584,0.00015755727,0.00024854767,0.0000023140663,0.00008719882,0.004378816,0.21032321,0.00025865933,0.70840937,0.00018995101],"about_ca_topic_score_codex":0.0074749948,"about_ca_topic_score_gemma":0.00028371066,"teacher_disagreement_score":0.94856435,"about_ca_system_score_codex":0.00017113177,"about_ca_system_score_gemma":0.00018130094,"threshold_uncertainty_score":0.99942523},"labels":[],"label_agreement":null},{"id":"W2398096896","doi":"10.1358/dot.2015.51.12.2420391","title":"Patiromer: A significant advance in the management of hyperkalemia","year":2015,"lang":"en","type":"review","venue":"Drugs of today","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyperkalemia; Medicine; Spironolactone; Kidney disease; Heart failure; Aldosterone; Adverse effect; Internal medicine; Urology","score_opus":0.029521000107332867,"score_gpt":0.3355143980820784,"score_spread":0.3059933979747455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398096896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007399379,0.95619816,0.0000022786085,0.00010096966,0.000105692176,0.0010096027,0.00003115206,0.000008617906,0.042469528],"genre_scores_gemma":[0.00055894355,0.9983223,0.00023326352,0.000034957735,0.000019912704,0.000073758725,0.00007088344,0.00002489391,0.00066107296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984171,0.000104379906,0.00065342657,0.00022021824,0.0004138566,0.00019103],"domain_scores_gemma":[0.9989014,0.00007917424,0.00037296448,0.0005423965,0.00004963201,0.000054409487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005334238,0.00022894797,0.0012776467,0.0001633546,0.000010441123,0.0000022719255,0.00030136458,0.00018617176,0.00003420801],"category_scores_gemma":[0.00001741184,0.00012367571,0.00030640003,0.00040704917,0.000103261504,0.000024195704,0.000055308796,0.00033365842,0.000027041895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001620672,0.00024343595,0.000009018443,0.029247325,0.00026480237,0.00006109468,0.00041775682,0.0000015163811,6.3694574e-7,0.00028027035,0.0023969752,0.967061],"study_design_scores_gemma":[0.00066448655,0.0000770343,0.00003280172,0.016982269,0.0012624493,0.000011258075,0.0006147279,0.0000014908834,0.0000013078744,0.00006688601,0.98016155,0.00012376728],"about_ca_topic_score_codex":0.000026676964,"about_ca_topic_score_gemma":7.3709856e-7,"teacher_disagreement_score":0.97776455,"about_ca_system_score_codex":0.000053188687,"about_ca_system_score_gemma":0.00014367903,"threshold_uncertainty_score":0.50433487},"labels":[],"label_agreement":null},{"id":"W2410968598","doi":"10.1358/dot.2004.40.7.850479","title":"Recent developments in lipid-lowering therapy - Highlights from theAtorvastatin Landmark Program: Global Investigators Meeting III","year":2004,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Landmark; Guideline; Clinical trial; Clinical Practice; Modalities; Medical physics; Family medicine; Pharmacology; Pathology; Artificial intelligence; Computer science","score_opus":0.015449924834143256,"score_gpt":0.27475283255909616,"score_spread":0.2593029077249529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410968598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917538,0.0021196364,0.000018582181,0.0010812203,0.00027763893,0.0008894343,0.00001029427,0.000088114895,0.003761243],"genre_scores_gemma":[0.9877288,0.00200524,0.009465068,0.00041934138,0.0002095999,0.000080321144,0.00004805972,0.000025784193,0.000017823815],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981783,0.00006203908,0.0004896227,0.0003366098,0.00056553114,0.00036790644],"domain_scores_gemma":[0.9991878,0.000022459279,0.00012716977,0.0003537828,0.00008358842,0.00022519066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058994326,0.0002034978,0.00050097145,0.000070678834,0.000059045804,0.000017172086,0.00013033529,0.000109337474,0.000028240458],"category_scores_gemma":[0.000062965664,0.00015942716,0.00013306394,0.0003811787,0.00005397591,0.000073771385,0.000052093306,0.00015539651,0.000009287612],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048594704,0.0007085108,0.06079326,0.00014319502,0.00045980295,0.00008161079,0.0047698785,0.000059757378,0.0018083164,0.0004221084,0.000205142,0.9300625],"study_design_scores_gemma":[0.033772707,0.0008585689,0.43496582,0.0042416775,0.00013848288,0.00003458997,0.001838496,0.000023723624,0.20101288,0.0021485977,0.31989002,0.001074449],"about_ca_topic_score_codex":0.0043465425,"about_ca_topic_score_gemma":0.00019459896,"teacher_disagreement_score":0.92898804,"about_ca_system_score_codex":0.00032657804,"about_ca_system_score_gemma":0.00047944314,"threshold_uncertainty_score":0.6570701},"labels":[],"label_agreement":null},{"id":"W2412549228","doi":"10.1358/dot.2015.51.6.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20,2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychiatry; Association (psychology); Addiction; Theme (computing); Gerontology; Psychotherapist; Psychology","score_opus":0.01329601164486981,"score_gpt":0.2968485207447442,"score_spread":0.2835525090998744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412549228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9316617,0.00076958135,0.000044446697,0.010286109,0.00058973883,0.00024918374,0.00008152189,0.00006397863,0.056253694],"genre_scores_gemma":[0.991874,0.000021088134,0.0006064392,0.0006259416,0.00023242975,0.000008432502,0.000060285787,0.000030083123,0.0065413257],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801016,0.00010243703,0.00034856677,0.00024242117,0.0009870135,0.00030938452],"domain_scores_gemma":[0.99840295,0.00012373217,0.00048348957,0.00027866478,0.00048326596,0.00022790089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005556031,0.00015852913,0.00041237642,0.000058769376,0.000054588065,0.000010592241,0.000108658045,0.00006220836,0.00015400875],"category_scores_gemma":[0.0006913215,0.00015540502,0.000093018156,0.00026039957,0.000034578617,0.00021043465,0.000042675052,0.00016757334,0.000020214045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017960963,0.0004445347,0.56351703,0.000061931656,0.00023816946,0.000008150477,0.0019977544,0.000102659265,0.0003440911,0.00011523486,0.42296603,0.010024805],"study_design_scores_gemma":[0.008612377,0.0011344482,0.22741862,0.00017410469,0.00092448073,0.00004621524,0.1558772,0.0006692125,0.0008416865,0.00012295815,0.6029404,0.0012382958],"about_ca_topic_score_codex":0.45424747,"about_ca_topic_score_gemma":0.42587763,"teacher_disagreement_score":0.33609843,"about_ca_system_score_codex":0.0015186603,"about_ca_system_score_gemma":0.00090523384,"threshold_uncertainty_score":0.6337233},"labels":[],"label_agreement":null},{"id":"W2442538157","doi":"10.1358/dot.2015.51.5.2336329","title":"A report from the American Association of Urology Annual Meeting2015 (May 15-19 - New Orleans, Louisiana, USA)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Convention; Quarter (Canadian coin); Gerontology; Family medicine; Library science; Archaeology","score_opus":0.019357152547271227,"score_gpt":0.3010949530022958,"score_spread":0.28173780045502456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442538157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95780003,0.0010662079,0.00008357524,0.024622105,0.0004360884,0.0003804789,0.00024211343,0.000036654215,0.015332756],"genre_scores_gemma":[0.99261284,0.00003821085,0.0006032295,0.0015182683,0.00038438506,0.000006598541,0.00006790201,0.000018804025,0.004749777],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986186,0.00010320057,0.00038042216,0.0002188908,0.00048314384,0.00019573959],"domain_scores_gemma":[0.99839497,0.00019949877,0.0006237803,0.00039203954,0.00020508029,0.00018463243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050602393,0.0001256291,0.00045177812,0.0000437452,0.000023586492,0.0000045569955,0.00013341015,0.000068166024,0.00011141867],"category_scores_gemma":[0.00074333395,0.000087524,0.000107818116,0.00018655903,0.00009437869,0.000048016995,0.00004239479,0.00012353853,0.000029290324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061926275,0.00017691149,0.584323,0.000008956731,0.00045439208,0.00005156992,0.0056342473,0.000012941702,0.00034652662,0.000037519232,0.3994229,0.008911781],"study_design_scores_gemma":[0.006187893,0.0015827451,0.4793979,0.00006192367,0.0011266809,0.00005276706,0.0037029365,0.000025227007,0.004760047,0.0010690743,0.5017753,0.00025747283],"about_ca_topic_score_codex":0.026707338,"about_ca_topic_score_gemma":0.0004989119,"teacher_disagreement_score":0.104925066,"about_ca_system_score_codex":0.00014057521,"about_ca_system_score_gemma":0.0005429363,"threshold_uncertainty_score":0.9797739},"labels":[],"label_agreement":null},{"id":"W2526768593","doi":"10.1358/dot.2017.53.6.2662982","title":"Notable deals in the pharmaceutical industry in the first quarterof 2017","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry","score_opus":0.171942251902463,"score_gpt":0.40503993652769343,"score_spread":0.23309768462523042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526768593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017241939,0.8573987,0.000002531125,0.0014104714,0.00046046134,0.0008152514,0.0000094050565,0.00001089511,0.13971984],"genre_scores_gemma":[0.020452175,0.97530466,0.000004095749,0.0013817347,0.0018341013,0.00020456378,0.000032830045,0.000034201472,0.0007516409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983776,0.00008053117,0.0005915778,0.00030224893,0.00030556612,0.0003424677],"domain_scores_gemma":[0.9981728,0.00051813066,0.00048769044,0.0007383578,0.00007563988,0.0000073603424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018886712,0.00030206027,0.00082125905,0.00025141836,0.00016790771,0.000311212,0.002220427,0.00037515227,0.00022775054],"category_scores_gemma":[0.0002243391,0.00016752456,0.00026932952,0.0003508818,0.00014058778,0.00035515285,0.00024809092,0.001460148,0.00058505236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009488072,0.00030643496,0.000880279,0.010042353,0.000042611915,0.00006404787,0.00074625085,0.000001022401,1.0771074e-7,0.0096356105,0.028526518,0.9497453],"study_design_scores_gemma":[0.0001109283,0.0000041044764,0.00023586354,0.0059470814,0.00012721344,0.0000039297256,0.00035577227,0.000024726722,5.7576875e-7,0.00029634175,0.9927017,0.00019173743],"about_ca_topic_score_codex":0.0005474109,"about_ca_topic_score_gemma":0.0006903448,"teacher_disagreement_score":0.9641752,"about_ca_system_score_codex":0.000029449602,"about_ca_system_score_gemma":0.00006519884,"threshold_uncertainty_score":0.75198597},"labels":[],"label_agreement":null},{"id":"W2527154090","doi":"10.1358/dot.2016.52.8.2545018","title":"Notable deals in the pharmaceutical industry in the second quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.028387175496601576,"score_gpt":0.28666359607740216,"score_spread":0.2582764205808006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527154090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8332429,0.00029092238,0.000032811327,0.008009493,0.0002524106,0.00021727204,0.0000039267493,0.000011051434,0.15793924],"genre_scores_gemma":[0.99562025,0.000021514597,0.0000039890956,0.0015467303,0.0003501067,0.00002190508,8.687629e-7,0.0000063950733,0.00242826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991097,0.00004423053,0.00026224682,0.00014744316,0.00017923777,0.000257131],"domain_scores_gemma":[0.9990932,0.0005396908,0.00008149839,0.00021515487,0.00006436091,0.0000061195287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011122185,0.000098120494,0.00012122101,0.00009683777,0.000060424867,0.000077932425,0.0005282414,0.00009227353,0.00082120235],"category_scores_gemma":[0.000106750675,0.00004613092,0.00004618069,0.00027190402,0.00008894923,0.00035930437,0.00007521287,0.0002829633,0.0004058394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002974231,0.0011007633,0.2114989,0.00036671353,0.000054833115,0.000080137426,0.0045358352,0.0000037183636,0.010348131,0.24733505,0.17193277,0.35244572],"study_design_scores_gemma":[0.0005773673,0.0000116084275,0.022455543,0.00020918313,0.000008764251,0.0000013084642,0.0025932644,0.00008210876,0.002677218,0.0071680853,0.96406287,0.00015266919],"about_ca_topic_score_codex":0.00013672585,"about_ca_topic_score_gemma":0.0006828678,"teacher_disagreement_score":0.7921301,"about_ca_system_score_codex":0.000014797936,"about_ca_system_score_gemma":0.000019555644,"threshold_uncertainty_score":0.899159},"labels":[],"label_agreement":null},{"id":"W2701201582","doi":"10.1358/dot.2017.53.5.2613690","title":"Brodalumab: The first anti-IL-17 receptor agent for psoriasis","year":2017,"lang":"en","type":"review","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Psoriasis Area and Severity Index; Psoriasis; Ustekinumab; Psoriatic arthritis; Dermatology; Interleukin 17; Clinical trial; Erythroderma; Immunology; Internal medicine; Adalimumab; Immune system; Disease","score_opus":0.06135471088143997,"score_gpt":0.31812742397030314,"score_spread":0.2567727130888632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2701201582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038754708,0.98936635,0.0000093234,0.00031053196,0.004518044,0.0016661154,0.002116552,0.0000508666,0.0019234829],"genre_scores_gemma":[0.000061551684,0.97845703,0.00008611505,0.000054905177,0.0003625709,0.00059875345,0.0012903801,0.00007357537,0.019015135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778056,0.00028660565,0.0007594603,0.00058914634,0.000067496236,0.00051671517],"domain_scores_gemma":[0.9964186,0.0009035116,0.0011166736,0.001430285,0.00010482273,0.00002613255],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000777735,0.0006085074,0.0021581007,0.00014979062,0.0007130123,0.000039624174,0.0013210607,0.0008230534,0.0005078084],"category_scores_gemma":[0.00021049104,0.00037227658,0.0015829145,0.00009446677,0.00028620203,0.00006739952,0.00019873498,0.00026568543,0.00085485255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034753015,0.0001133031,0.000006157216,0.0022773754,0.0016403765,0.0000010678942,0.00019704913,1.1558528e-7,0.000010407157,0.000115260584,0.1268715,0.86873263],"study_design_scores_gemma":[0.0008680641,0.0001056996,0.000013937313,0.0026928,0.002708789,0.000012323937,0.00003640499,4.9228497e-8,0.00030091513,0.000019577996,0.99286556,0.00037586136],"about_ca_topic_score_codex":0.00007704298,"about_ca_topic_score_gemma":0.000024275892,"teacher_disagreement_score":0.86835676,"about_ca_system_score_codex":0.000093240255,"about_ca_system_score_gemma":0.00020614357,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W2766470987","doi":"10.1358/dot.2017.53.8.2701432","title":"Notable licensing deals in the biopharma industry in the secondquarter of 2017","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine","score_opus":0.024488112195380034,"score_gpt":0.31985902365674423,"score_spread":0.2953709114613642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766470987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92299134,0.00033105403,9.78017e-7,0.056179434,0.00010085127,0.000166318,0.0000021671135,0.0000048621837,0.020223016],"genre_scores_gemma":[0.99812746,0.00009494575,0.000038268372,0.0014308721,0.00003478777,0.0000030048463,0.0000013011894,0.0000038371845,0.00026549477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994088,0.000047731442,0.00020496295,0.00009471749,0.00010331962,0.00014047323],"domain_scores_gemma":[0.9991569,0.000090819995,0.00014938631,0.0005673586,0.000023148601,0.0000123801865],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006655626,0.00006673903,0.00018491848,0.00008078494,0.000072339666,0.000008044126,0.00034829232,0.0017604599,0.000054503125],"category_scores_gemma":[0.00008494395,0.000035131234,0.000043440537,0.00007545775,0.00022233998,0.000057097626,0.000036946843,0.0027109599,0.000008433244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014609499,0.0034631044,0.3330098,0.0011878561,0.00071747304,0.0011903452,0.12269535,0.000050385683,0.25291008,0.023667635,0.13275531,0.12689167],"study_design_scores_gemma":[0.006027838,0.00036681557,0.72624457,0.0012299725,0.000179959,0.00022582676,0.014477831,0.00025326267,0.21990709,0.001192201,0.029611124,0.0002834965],"about_ca_topic_score_codex":0.00021963638,"about_ca_topic_score_gemma":0.000031712258,"teacher_disagreement_score":0.39323476,"about_ca_system_score_codex":0.0000057963466,"about_ca_system_score_gemma":0.00003061928,"threshold_uncertainty_score":0.9995898},"labels":[],"label_agreement":null},{"id":"W2793596767","doi":"10.1358/dot.2017.53.12.2717629","title":"European Society of Cardiology Congress 2017 (August 26-30, 2017 -Barcelona, Spain)","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Coronary artery disease; Canadian Cardiovascular Society; Coronary heart disease; Cardiology; Interventional cardiology; Internal medicine; Myocardial infarction; Angina","score_opus":0.03421157514825694,"score_gpt":0.31302736387924857,"score_spread":0.2788157887309916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793596767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7431845,0.001338064,0.00045417392,0.0030972084,0.0013766725,0.0004300108,0.00023666756,0.00006586868,0.24981685],"genre_scores_gemma":[0.9906419,0.00058436254,0.0004821022,0.00011294157,0.00026178116,0.0000043182135,0.00003143676,0.000027263228,0.007853876],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9989308,0.000071542505,0.0003714681,0.00022224078,0.00018918453,0.00021475022],"domain_scores_gemma":[0.9980396,0.00014634294,0.0003917951,0.0010581334,0.00025576106,0.00010839233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005016475,0.00014297596,0.00047919786,0.00004128493,0.00016222437,0.00001683251,0.00039283186,0.00008468955,0.00032010354],"category_scores_gemma":[0.00034382512,0.0001261795,0.00047613608,0.000019494739,0.00048062825,0.00007911368,0.0002556578,0.00016280955,0.00013204955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019474894,0.00040901385,0.16049019,0.00061672303,0.00069580524,0.00025322562,0.0007700155,0.00004503973,0.0036991944,0.0014157724,0.80732113,0.024089163],"study_design_scores_gemma":[0.0035323205,0.000651343,0.74843156,0.0008063495,0.00036866614,0.00006463022,0.00072845194,0.00016518593,0.0033385272,0.00017255415,0.24146533,0.0002750663],"about_ca_topic_score_codex":0.00019559974,"about_ca_topic_score_gemma":0.0000062670883,"teacher_disagreement_score":0.5879414,"about_ca_system_score_codex":0.000021771612,"about_ca_system_score_gemma":0.000061179395,"threshold_uncertainty_score":0.514545},"labels":[],"label_agreement":null},{"id":"W2796263169","doi":"10.1358/dot.2018.54.10.2909247","title":"Life sciences licensing deals in the second quarter of 2018:updates and trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; License; Portfolio; Value (mathematics); Finance; Business; Law","score_opus":0.009292596359820824,"score_gpt":0.23276833504700076,"score_spread":0.22347573868717993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796263169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932354,0.0003983915,0.00004470012,0.0008574261,0.00021043084,0.000018313825,0.0000037057894,0.000015272373,0.0052163564],"genre_scores_gemma":[0.99940866,0.00001431463,0.0003861041,0.00006764116,0.00007828348,0.0000011201466,0.0000011690422,0.0000031928548,0.00003949867],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99965376,0.000007981342,0.000117898744,0.000055272958,0.00007710042,0.000087962835],"domain_scores_gemma":[0.99982315,0.00005374844,0.00001593879,0.000067834335,0.000010019161,0.000029303648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022904112,0.000044226388,0.00007646387,0.00009204011,0.000015899652,0.000006247409,0.00008128118,0.000029711704,0.00008851414],"category_scores_gemma":[0.0000186782,0.000030042762,0.000011541937,0.00019686324,0.00013838921,0.000057618512,0.0000075241983,0.000039721657,0.0000025769834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034695007,0.00035479473,0.013024314,0.002824062,0.0001818968,0.000001905265,0.124129914,0.00091252243,0.13013075,0.005599223,0.48025063,0.2425553],"study_design_scores_gemma":[0.0019414033,0.00091614213,0.54443645,0.0010258628,0.00007794138,0.000023965798,0.014524839,0.09091029,0.16570212,0.003388394,0.17583802,0.0012145822],"about_ca_topic_score_codex":0.000026486303,"about_ca_topic_score_gemma":0.000015762549,"teacher_disagreement_score":0.5314121,"about_ca_system_score_codex":0.0000035995392,"about_ca_system_score_gemma":0.000007062722,"threshold_uncertainty_score":0.12251083},"labels":[],"label_agreement":null},{"id":"W2804667058","doi":"10.1358/dot.2018.54.4.2795154","title":"Daclatasvir, asunaprevir and beclabuvir fixed-dose combination forpatients with genotype 1 chronic hepatitis C","year":2018,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Infectious Diseases Centre","funders":"","keywords":"Daclatasvir; Medicine; Internal medicine; Hepatitis C; Regimen; Hepatitis C virus; Virology; Adverse effect; Gastroenterology; Virus; Ribavirin","score_opus":0.03751225994869992,"score_gpt":0.34831314644824135,"score_spread":0.3108008864995414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804667058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018361548,0.9900295,0.000021111555,0.00006572369,0.0001617522,0.0026701102,0.00037162376,0.00005315638,0.0047908816],"genre_scores_gemma":[0.002267207,0.99389344,0.00048468966,0.00004547234,0.00020845169,0.00019367618,0.0012706969,0.00013836003,0.0014979973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967022,0.00025630163,0.00085103145,0.000691121,0.0009820608,0.0005172901],"domain_scores_gemma":[0.99755716,0.00024049467,0.00055517297,0.0009441347,0.00040860265,0.00029444956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055755896,0.0005270781,0.0020061359,0.000472488,0.00011702429,0.000040433413,0.00034008373,0.00042171968,0.0004401375],"category_scores_gemma":[0.00025456696,0.00040118606,0.0002432455,0.0005194486,0.0004144042,0.00020333186,0.0002688648,0.0005999688,0.0002958914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048883478,0.00017028455,0.0010097476,0.024609432,0.00037601066,0.000030471905,0.00014028147,6.5803356e-8,0.0000020166888,0.00010947742,0.004306174,0.96919715],"study_design_scores_gemma":[0.0014755568,0.0019692662,0.00060550176,0.019936673,0.0008314164,0.000028402303,0.0000038719263,0.00004634565,0.000028668715,0.00003009352,0.9746683,0.00037585376],"about_ca_topic_score_codex":0.00073643797,"about_ca_topic_score_gemma":0.0002644903,"teacher_disagreement_score":0.9703622,"about_ca_system_score_codex":0.0005241841,"about_ca_system_score_gemma":0.0010587403,"threshold_uncertainty_score":0.999844},"labels":[],"label_agreement":null},{"id":"W2852054128","doi":"10.1358/dot.2018.54.6.2856494","title":"Life sciences licensing deals in the first quarter of 2018: updatesand trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Value (mathematics); Medicine; Statistics; Mathematics","score_opus":0.06580677129434757,"score_gpt":0.3849955914596011,"score_spread":0.3191888201652535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2852054128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87361676,0.0002641547,0.00005475515,0.024594018,0.0004403761,0.00007390266,0.000013563546,0.000009776098,0.10093272],"genre_scores_gemma":[0.9975455,0.000009389884,0.00026649339,0.0016176644,0.00017655657,0.0000018218009,9.2885557e-7,0.0000039275333,0.00037775547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969745,0.00020418226,0.0007715605,0.0003526945,0.0014277608,0.00026926122],"domain_scores_gemma":[0.9971036,0.0016157591,0.0004899432,0.00049766485,0.00021326478,0.00007978321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010092474,0.00010659991,0.000305711,0.0004769797,0.00021060916,0.00030964878,0.0030778293,0.00009843965,0.00043985265],"category_scores_gemma":[0.0037220453,0.00005752885,0.00008135176,0.0019812877,0.0008151074,0.0012462039,0.00021291002,0.00017564092,0.00006220345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036189533,0.000070085094,0.079621874,0.000005027836,0.00000938667,9.189701e-7,0.016530199,0.000030259085,0.0001105582,0.0020100274,0.87224215,0.029333316],"study_design_scores_gemma":[0.001861756,0.00061620394,0.32851833,0.00036241516,0.000044436692,0.000015335601,0.047310166,0.005333792,0.010716195,0.033390604,0.5710891,0.0007416543],"about_ca_topic_score_codex":0.0004854824,"about_ca_topic_score_gemma":0.00017022119,"teacher_disagreement_score":0.30115303,"about_ca_system_score_codex":0.000009987326,"about_ca_system_score_gemma":0.00011772121,"threshold_uncertainty_score":0.5719424},"labels":[],"label_agreement":null},{"id":"W2942062551","doi":"10.1358/dot.2019.55.4.2958476","title":"Encorafenib and binimetinib for the treatment of BRAFV600E/K-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Melanoma; MAPK/ERK pathway; Metastatic melanoma; V600E; Cancer research; Oncology; Kinase; Pharmacology; Mutation; Internal medicine; Biology; Genetics","score_opus":0.04074034639323368,"score_gpt":0.3182639523817377,"score_spread":0.277523605988504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942062551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019007359,0.9953208,0.000038713428,0.000017199924,0.0002678185,0.0012794676,0.00052166596,0.0000044087574,0.0006492175],"genre_scores_gemma":[0.0010995872,0.9959205,0.00021324882,0.000010560188,0.00015873747,0.00013982867,0.0005437486,0.00003913536,0.0018746924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988687,0.00007058049,0.00044640797,0.00034315826,0.0000905817,0.00018058409],"domain_scores_gemma":[0.9987227,0.0001963721,0.00042109424,0.00054410216,0.00006951325,0.000046272427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016406257,0.00029406146,0.00097099994,0.000055100132,0.00003428814,0.000007779531,0.00024130118,0.0002784668,0.000013912882],"category_scores_gemma":[0.000037732087,0.00017174995,0.0004958543,0.00006324753,0.000093045805,0.0000013554367,0.000057587302,0.000042252443,0.0000054117777],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005805655,0.0001342631,0.000012699645,0.0044779163,0.0007244644,6.406922e-7,0.00011235979,5.5920776e-7,0.0014279878,0.0001280815,0.0010288897,0.99189407],"study_design_scores_gemma":[0.0005617005,0.0012866043,0.0000050250815,0.00043509755,0.00087691663,0.000008492454,0.000026314692,0.0000030865629,0.009883668,0.0000117636455,0.9867259,0.00017543045],"about_ca_topic_score_codex":0.000026299525,"about_ca_topic_score_gemma":0.0000041515436,"teacher_disagreement_score":0.99171865,"about_ca_system_score_codex":0.000010563691,"about_ca_system_score_gemma":0.00016920581,"threshold_uncertainty_score":0.70037603},"labels":[],"label_agreement":null},{"id":"W2985958489","doi":"10.1358/dot.2019.55.10.3045038","title":"Viltolarsen for the treatment of Duchenne muscular dystrophy","year":2019,"lang":"en","type":"review","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Dystrophin; Exon skipping; Exon; Medicine; Morpholino; RNA splicing; Muscular dystrophy; Alternative splicing; Bioinformatics; Genetics; Internal medicine; Gene; Gene knockdown; RNA; Biology","score_opus":0.030203488749806395,"score_gpt":0.32160060725396694,"score_spread":0.29139711850416056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985958489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010016302,0.99721617,0.000067347246,0.000020635473,0.00023009501,0.0009916878,0.00022097056,0.0000028033764,0.00024869392],"genre_scores_gemma":[0.0014966666,0.9970536,0.000106521686,0.0000160009,0.00015118372,0.00016447323,0.0004976132,0.000030314588,0.00048357536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990672,0.00006555924,0.0003324567,0.00029858956,0.00006634387,0.0001698552],"domain_scores_gemma":[0.9988034,0.00009725532,0.0003146678,0.000691623,0.000066411114,0.000026643247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093322655,0.0002501539,0.000840217,0.000034515127,0.000035165867,0.0000030248405,0.000300317,0.00029037194,0.000016839751],"category_scores_gemma":[0.000029555322,0.0001493791,0.0009823282,0.000049095666,0.00011130671,0.0000011545932,0.000043132808,0.00004417673,0.0000063674056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012658382,0.00036320149,0.0000027871502,0.0074174316,0.0016363728,3.1167156e-7,0.00007710884,0.000022253,0.0018407791,0.00027468224,0.0013357594,0.9869027],"study_design_scores_gemma":[0.0004330933,0.00070164254,0.000004439929,0.00025184083,0.0007858467,9.102894e-7,0.000025799134,0.0000021044793,0.0009198847,0.00003217853,0.99669856,0.0001436795],"about_ca_topic_score_codex":0.00002374945,"about_ca_topic_score_gemma":0.00000259133,"teacher_disagreement_score":0.9953628,"about_ca_system_score_codex":0.00001040948,"about_ca_system_score_gemma":0.00012699193,"threshold_uncertainty_score":0.60915035},"labels":[],"label_agreement":null},{"id":"W3006524053","doi":"10.1358/dot.2020.56.1.3069863","title":"Galcanezumab: a humanized monoclonal antibody for the prevention ofmigraine and cluster headache","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Migraine; Medicine; Triptans; Calcitonin gene-related peptide; Cluster headache; Chronic Migraine; Headaches; Clinical trial; Rizatriptan; Pharmacology; Bioinformatics; Internal medicine; Sumatriptan; Receptor; Psychiatry; Neuropeptide","score_opus":0.03827635726970599,"score_gpt":0.3370591633159204,"score_spread":0.29878280604621443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006524053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8589442,0.0066194604,0.0029012752,0.124528736,0.00003797219,0.0022296861,0.000051891282,0.00007394266,0.004612832],"genre_scores_gemma":[0.99127877,0.00024300453,0.0015832093,0.0023397875,0.00030778025,0.00004184772,0.000041465653,0.000017618197,0.0041465317],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999215,0.000025300535,0.00024810698,0.00018613887,0.00016596007,0.00015950772],"domain_scores_gemma":[0.9993938,0.00020696505,0.00008644213,0.0001409048,0.000100157056,0.000071682145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002591618,0.00011904054,0.00032037226,0.000029916971,0.00010547668,0.00000857968,0.000066572116,0.000044916516,0.00006725313],"category_scores_gemma":[0.00020270163,0.000076234144,0.00016425218,0.000083407445,0.000094644216,0.000039203747,0.00006221234,0.000105622035,0.0000034024174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061101657,0.00065905333,0.013495695,0.0035173572,0.0021732696,0.000011072533,0.052097782,0.000011482197,0.09152832,0.00704205,0.80454934,0.01880439],"study_design_scores_gemma":[0.028563842,0.0055693723,0.09348611,0.00072714826,0.0025846057,0.00006542754,0.013517937,0.016513579,0.017151194,0.0021734596,0.8188173,0.0008299909],"about_ca_topic_score_codex":0.00007126826,"about_ca_topic_score_gemma":0.000032673033,"teacher_disagreement_score":0.13233455,"about_ca_system_score_codex":0.000009342285,"about_ca_system_score_gemma":0.000043618038,"threshold_uncertainty_score":0.3108738},"labels":[],"label_agreement":null},{"id":"W3047556542","doi":"10.1358/dot.2020.56.8.3159186","title":"Golodirsen for Duchenne muscular dystrophy","year":2020,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Exon skipping; Duchenne muscular dystrophy; Exon; Medicine; Dystrophin; Morpholino; Muscular dystrophy; Gene; Bioinformatics; Genetics; Antisense therapy; Internal medicine; Gene knockdown; Biology; Oligonucleotide; Alternative splicing","score_opus":0.0094307765891266,"score_gpt":0.23215111052016882,"score_spread":0.2227203339310422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047556542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450445,0.000435761,0.0015081981,0.0016468209,0.000082993814,0.0001958629,0.000048214843,0.000011347676,0.0015663754],"genre_scores_gemma":[0.9976798,0.00003502857,0.0009200905,0.0009222474,0.00017814239,0.00002155494,0.00013294804,0.000012445427,0.000097689255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944955,0.000020392343,0.00012411692,0.00022024607,0.000044979588,0.00014070461],"domain_scores_gemma":[0.99964696,0.000010956563,0.000053953805,0.00017258624,0.00005244076,0.00006308496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005269606,0.00008847899,0.00013011953,0.000010678672,0.000031724554,0.0000029141304,0.00014865387,0.000094160656,0.000026881658],"category_scores_gemma":[0.000098869285,0.00008377368,0.00013536366,0.000036604062,0.00006575133,0.0000018918954,0.00005515642,0.000034904213,0.000008031533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039321146,0.00004875636,0.00018292926,0.00007461049,0.000081047605,4.0870393e-7,0.00015853347,0.0001445136,0.98416334,0.00074329175,0.012040006,0.0019693282],"study_design_scores_gemma":[0.0025362778,0.0013016902,0.0018422509,0.000010691512,0.000062644554,0.0000010024266,0.00041860426,0.00024311396,0.6516961,0.0010990393,0.34040028,0.0003883107],"about_ca_topic_score_codex":0.000007620752,"about_ca_topic_score_gemma":0.0000010443983,"teacher_disagreement_score":0.3324673,"about_ca_system_score_codex":0.0000016097035,"about_ca_system_score_gemma":0.000025554098,"threshold_uncertainty_score":0.34161916},"labels":[],"label_agreement":null},{"id":"W3119281289","doi":"10.1358/dot.2021.57.1.3211618","title":"Apomorphine hydrochloride: A sublingual tablet for the OFF episodesin Parkinson's disease","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Apomorphine; Levodopa; Parkinson's disease; Disease; Pediatrics; Anesthesia; Dopamine; Internal medicine; Dopaminergic","score_opus":0.018341829861007318,"score_gpt":0.2748438631171107,"score_spread":0.2565020332561034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119281289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96190643,0.016485296,0.0017499527,0.015030182,0.0008021664,0.0014418114,0.0009770832,0.00011444472,0.0014926362],"genre_scores_gemma":[0.9923852,0.00039553948,0.0011300864,0.0009391748,0.00034628916,0.00016582,0.0002924182,0.00004237448,0.0043030907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985382,0.000034688488,0.0002887202,0.00039655276,0.00039389834,0.0003479248],"domain_scores_gemma":[0.99841595,0.00027672804,0.00013358892,0.00060434296,0.00024286396,0.00032654402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000251044,0.0002198572,0.0003954037,0.000066577755,0.00014816197,0.000028534629,0.00014630245,0.000059283197,0.000305122],"category_scores_gemma":[0.0003864342,0.00015384209,0.00031551038,0.0002360714,0.00007311404,0.00007495556,0.00007366647,0.00010059243,0.000023809123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03132253,0.023782348,0.1124108,0.0052109463,0.011628966,0.0081349835,0.0048158355,0.0008342674,0.058287587,0.048291594,0.21350344,0.4817767],"study_design_scores_gemma":[0.0072149257,0.00022957409,0.031770624,0.00023593745,0.0015157355,0.00003321311,0.00032456024,0.0034352064,0.058241013,0.0026988138,0.89398843,0.00031199428],"about_ca_topic_score_codex":0.0000483062,"about_ca_topic_score_gemma":0.000008329308,"teacher_disagreement_score":0.68048495,"about_ca_system_score_codex":0.000057533543,"about_ca_system_score_gemma":0.00039294866,"threshold_uncertainty_score":0.62734985},"labels":[],"label_agreement":null},{"id":"W3120200411","doi":"10.1358/dot.2021.57.1.3233361","title":"Recombinant vesicular stomatitis virus expressing Ebola virusglycoprotein (rVSV-EBOV), a new Ebola vaccine","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women and Children’s Health Research Institute; University of Alberta","funders":"","keywords":"Ebola vaccine; Ebola virus; Virology; Vesicular stomatitis virus; Ebolavirus; Sierra leone; Outbreak; Medicine; Vaccination; Virus","score_opus":0.01607867106629849,"score_gpt":0.2971816121544201,"score_spread":0.2811029410881216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120200411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759404,0.003809041,0.0014182626,0.00319912,0.0005257251,0.00063644105,0.000024515522,0.00014131778,0.014305191],"genre_scores_gemma":[0.9745812,0.00047518397,0.0060563413,0.00049688225,0.00039319982,0.00004474365,0.000058999438,0.00007196997,0.017821496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788654,0.00012926331,0.0005336934,0.00042341815,0.00057015603,0.00045695127],"domain_scores_gemma":[0.9985066,0.000082879145,0.00014217287,0.00061976095,0.00031528404,0.00033327134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037341693,0.0002347524,0.0005884129,0.00021961717,0.00016050707,0.000066439214,0.00014374143,0.0001623191,0.0015782706],"category_scores_gemma":[0.00028194964,0.00020629026,0.0002658986,0.0005075605,0.00004744589,0.00019483143,0.00018572013,0.0003971456,0.00016404079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016485009,0.00041880165,0.0005052185,0.00022643733,0.00014926048,0.00039899632,0.0005418855,0.00001187039,0.83265287,0.00032779592,0.020608839,0.14399317],"study_design_scores_gemma":[0.0029042738,0.0003346165,0.0051761223,0.00071446487,0.00009638964,0.00020238303,0.00025417496,0.0003324008,0.88474864,0.0005222521,0.104464054,0.00025021014],"about_ca_topic_score_codex":0.002355893,"about_ca_topic_score_gemma":0.000104594816,"teacher_disagreement_score":0.14374296,"about_ca_system_score_codex":0.00011074635,"about_ca_system_score_gemma":0.0004577691,"threshold_uncertainty_score":0.9993344},"labels":[],"label_agreement":null},{"id":"W3161179238","doi":"10.1358/dot.2021.57.5.3264119","title":"Remimazolam: a short-acting benzodiazepine for procedural sedation","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Benzodiazepine; Sedation; Anesthesia; Internal medicine","score_opus":0.0334317832994494,"score_gpt":0.31676419088883834,"score_spread":0.28333240758938893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161179238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861033,0.000151959,0.0017355882,0.004356787,0.0000867232,0.00046152627,0.000011543156,0.00003960051,0.0070530055],"genre_scores_gemma":[0.99094516,0.000013850754,0.00538246,0.0007543685,0.00013112274,0.0000261582,0.00022066376,0.00001653262,0.002509692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99928355,0.000016569107,0.0002168576,0.0001773298,0.0001585519,0.00014714102],"domain_scores_gemma":[0.99938893,0.00007507586,0.00006665961,0.00015415733,0.00025625867,0.000058901143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014428589,0.00008548268,0.00022710812,0.000039147537,0.00004381587,0.000006722037,0.000041675856,0.000051477677,0.00011308328],"category_scores_gemma":[0.00032584232,0.00007642786,0.00009849439,0.000116760246,0.00002183349,0.000084954234,0.000016821683,0.00006546683,0.0000072121165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014282236,0.0011626115,0.094035715,0.0026834626,0.00052692293,0.00016372105,0.011816757,0.00003201433,0.66954285,0.003355503,0.031367153,0.18388507],"study_design_scores_gemma":[0.0030324864,0.00046069676,0.056581832,0.0005614629,0.00031020408,0.0001081597,0.004914958,0.0021753542,0.849622,0.0003623165,0.08151599,0.00035453038],"about_ca_topic_score_codex":0.0000058424316,"about_ca_topic_score_gemma":0.0000025065992,"teacher_disagreement_score":0.18353052,"about_ca_system_score_codex":0.000028286358,"about_ca_system_score_gemma":0.00011637902,"threshold_uncertainty_score":0.31166378},"labels":[],"label_agreement":null},{"id":"W3189922281","doi":"10.1358/dot.2021.57.8.3293588","title":"Vibegron: a beta3-adrenergic agonist for the treatment ofoveractive bladder","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nocturia; Medicine; Overactive bladder; Anticholinergic; Agonist; Oxybutynin; Urology; Urinary urgency; Urinary incontinence; Anticholinergic agents; Urinary bladder; Adrenergic; Urinary system; Mirabegron; Internal medicine; Receptor; Pathology","score_opus":0.02997721073690499,"score_gpt":0.33147762763836036,"score_spread":0.30150041690145535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189922281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81636286,0.02170094,0.00062949903,0.046446007,0.0007646077,0.0033396974,0.0005728991,0.00009657717,0.11008692],"genre_scores_gemma":[0.967151,0.0019054144,0.00057597586,0.0003005902,0.00026736362,0.00015853599,0.00013268852,0.000026254167,0.029482173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900275,0.000046629775,0.00018108857,0.00023309434,0.00026956171,0.00026686722],"domain_scores_gemma":[0.99872196,0.00050667423,0.00005039331,0.00039787506,0.00022673814,0.0000963728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015525271,0.00013142441,0.00026766094,0.000039649847,0.00013292821,0.000020631871,0.000083078776,0.00005246004,0.0006026862],"category_scores_gemma":[0.00004780742,0.000079951395,0.00023284936,0.00014167752,0.000098296965,0.000050802784,0.00003830389,0.00010348879,0.000022995033],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011254652,0.012904493,0.006757481,0.0012037094,0.011716378,0.0010679496,0.03911892,0.0003183499,0.0784123,0.010017741,0.08103118,0.74619687],"study_design_scores_gemma":[0.006104803,0.0029651306,0.008297634,0.0000751627,0.0006836118,0.00010298441,0.003799172,0.0006108513,0.3814734,0.0007984676,0.5948601,0.0002286904],"about_ca_topic_score_codex":0.00013874623,"about_ca_topic_score_gemma":0.00002115175,"teacher_disagreement_score":0.74596816,"about_ca_system_score_codex":0.00007847748,"about_ca_system_score_gemma":0.000331815,"threshold_uncertainty_score":0.6598991},"labels":[],"label_agreement":null},{"id":"W4200087363","doi":"10.1358/dot.2021.57.12.3352740","title":"Casimersen for Duchenne muscular dystrophy","year":2021,"lang":"en","type":"article","venue":"Drugs of today","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Medicine; Exon skipping; Duchenne muscular dystrophy; Dystrophin; Exon; Muscular dystrophy; Population; Antisense therapy; Bioinformatics; Clinical trial; Pharmacology; Internal medicine; Genetics; Gene; Oligonucleotide; Biology; Alternative splicing","score_opus":0.005900815163805081,"score_gpt":0.24271226631614984,"score_spread":0.23681145115234475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200087363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995238,0.00095722225,0.00073943904,0.00034790457,0.00015664287,0.00010467761,0.000039986757,0.0000056033073,0.0024104966],"genre_scores_gemma":[0.9974068,0.00006989207,0.0012085579,0.00026504512,0.00011029474,0.000018522596,0.00023960229,0.00001163959,0.0006696613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944824,0.000027497805,0.00011560839,0.00021727124,0.000045554007,0.00014585686],"domain_scores_gemma":[0.9995272,0.000013770315,0.000045107645,0.00026701624,0.0001089166,0.000038001243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006570451,0.00008073893,0.00012032581,0.000013817916,0.000038547096,0.0000033765448,0.00008964989,0.00009782893,0.000044805347],"category_scores_gemma":[0.00008801068,0.00008066053,0.00014501165,0.000039959945,0.000058612295,0.0000016631183,0.000052697695,0.000030721923,0.0000042489037],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113716414,0.00007725123,0.00014441276,0.000044994424,0.0000947691,0.0000017117719,0.000056838446,0.00007612749,0.99184126,0.00076274946,0.0044344403,0.002351737],"study_design_scores_gemma":[0.0010686667,0.00019384055,0.0012536317,0.000008354922,0.00003792848,0.0000035294222,0.00035435837,0.000026352653,0.86827815,0.00094248867,0.12765644,0.0001762591],"about_ca_topic_score_codex":0.000012362251,"about_ca_topic_score_gemma":0.0000066246394,"teacher_disagreement_score":0.1235631,"about_ca_system_score_codex":0.0000025346233,"about_ca_system_score_gemma":0.00005936273,"threshold_uncertainty_score":0.3289241},"labels":[],"label_agreement":null},{"id":"W4200565889","doi":"10.1358/dot.2021.57.12.3352760","title":"Delgocitinib in atopic dermatitis","year":2021,"lang":"en","type":"review","venue":"Drugs of today","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Tacrolimus; Calcineurin; Pimecrolimus; Janus kinase; Clinical trial; Dermatology; Safety profile; Ciclosporin; Pharmacology; Quality of life (healthcare); Pharmacokinetics; Janus kinase inhibitor; Adverse effect; Immunology; Transplantation; Internal medicine; Cytokine","score_opus":0.02845163800676103,"score_gpt":0.3400481662397611,"score_spread":0.31159652823300005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200565889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010798301,0.98590875,0.0000016560447,0.00017235632,0.00017381273,0.00031193852,0.00004203204,0.00001942525,0.013262051],"genre_scores_gemma":[0.00052324886,0.9976839,0.00012755553,0.00030435098,0.000060869414,0.000051288018,0.0003215825,0.00002325679,0.0009039391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998716,0.00013837726,0.0005876716,0.00021911816,0.00015231656,0.0001865046],"domain_scores_gemma":[0.99910796,0.00022054478,0.00018106736,0.00035664963,0.00004953958,0.00008422713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009102388,0.00020355525,0.0018603621,0.00018476397,0.000015490028,0.000005051694,0.00012766446,0.0002911868,0.0005441038],"category_scores_gemma":[0.00017975931,0.00017259641,0.00047264833,0.00022999031,0.00007434035,0.000030918993,0.000061676576,0.00027553283,0.00008512101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012523844,0.00014573832,0.0008855612,0.03340178,0.00017070599,0.000801312,0.000117292286,4.2520423e-8,2.1841588e-8,0.00032669128,0.033754572,0.930395],"study_design_scores_gemma":[0.00033048526,0.000006361739,0.0004993005,0.026880063,0.0005251458,0.00028498372,0.00003293334,5.337632e-7,0.0000034347097,0.000048278103,0.97125953,0.00012896434],"about_ca_topic_score_codex":0.000017135786,"about_ca_topic_score_gemma":0.0000050267217,"teacher_disagreement_score":0.93750495,"about_ca_system_score_codex":0.000036090074,"about_ca_system_score_gemma":0.00041882208,"threshold_uncertainty_score":0.70382774},"labels":[],"label_agreement":null},{"id":"W4210789185","doi":"10.1358/dot.2022.58.1.3353167","title":"Estetrol and drospirenone: a novel oral contraceptive","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Drospirenone; Estrogen; Endocrine system; Estrogen receptor; Endometrial cancer; Agonist; Pharmacology; Endometrium; Internal medicine; Endocrinology; Gynecology; Physiology; Receptor; Cancer; Hormone; Breast cancer","score_opus":0.014209523293942594,"score_gpt":0.27995647232749604,"score_spread":0.26574694903355345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210789185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917941,0.000766825,0.0002889117,0.004502738,0.00018962129,0.0005115393,0.000031249016,0.000028707498,0.001886287],"genre_scores_gemma":[0.9973114,0.000022110733,0.00054136047,0.0006489472,0.00011771883,0.00006702245,0.000014193472,0.000011831533,0.0012654277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991045,0.000037068177,0.00019905652,0.00024084454,0.00024415762,0.00017438339],"domain_scores_gemma":[0.99947995,0.000043073913,0.00010350158,0.00019147097,0.00008367361,0.0000983233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035599264,0.00008318207,0.00025237034,0.000068883164,0.00010915371,0.0000040848986,0.000041416897,0.00002692661,0.00023515928],"category_scores_gemma":[0.000090539055,0.000077372744,0.000048948998,0.00011717868,0.00007452143,0.000053734373,0.00004758645,0.00018951063,0.0000050588774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006587033,0.003030669,0.10845546,0.0006460175,0.00037225735,0.000055067067,0.016044853,0.00011414952,0.38758102,0.007300026,0.007874287,0.46193916],"study_design_scores_gemma":[0.022227228,0.005628581,0.80328804,0.00011509384,0.0003828738,0.00035952972,0.00948465,0.0019315279,0.01242352,0.0011196004,0.14242221,0.00061712065],"about_ca_topic_score_codex":0.000120456185,"about_ca_topic_score_gemma":0.0000026826078,"teacher_disagreement_score":0.6948326,"about_ca_system_score_codex":0.000058424674,"about_ca_system_score_gemma":0.00008561543,"threshold_uncertainty_score":0.3155169},"labels":[],"label_agreement":null},{"id":"W4212843950","doi":"10.1358/dot.2022.58.2.3367993","title":"Loteprednol etabonate: a formulation for short-term use in inflammatory flares in dry eye disease","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Corticosteroid; Pharmacokinetics; Ophthalmology; Pharmacology; Internal medicine","score_opus":0.014644914344653344,"score_gpt":0.26912812639385025,"score_spread":0.2544832120491969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212843950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825794,0.00037970184,0.00002880052,0.0002948918,0.00008878252,0.00078539056,0.000056477413,0.000023280729,0.00008474654],"genre_scores_gemma":[0.9990351,0.000016889247,0.00011541137,0.00014063403,0.000026839467,0.00013910302,0.00012305808,0.000021836247,0.00038108582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900717,0.000043960914,0.00030822703,0.0001940557,0.00025042132,0.00019619252],"domain_scores_gemma":[0.99949425,0.000068102825,0.00005564986,0.0002663117,0.000041073687,0.0000746098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024949355,0.00010504093,0.00022316778,0.00021283286,0.00003654038,0.00000943117,0.00008353839,0.000040749586,0.000055979755],"category_scores_gemma":[0.000084247724,0.00010774064,0.000109470326,0.00013701826,0.000011390698,0.00018496999,0.00007684919,0.0001568047,0.0000020365217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007537221,0.00017524639,0.98936516,0.00014401104,0.00001885695,0.00005088537,0.0012634515,0.0004018128,0.0044460245,0.0004159641,0.000015014066,0.0029498637],"study_design_scores_gemma":[0.0018912146,0.00008505773,0.990538,0.000095730764,0.000040622803,9.9089995e-8,0.00046803922,0.0024438116,0.0014665216,0.00016535475,0.0026827857,0.0001227487],"about_ca_topic_score_codex":0.00009373919,"about_ca_topic_score_gemma":0.0001276899,"teacher_disagreement_score":0.0029795028,"about_ca_system_score_codex":0.00010874728,"about_ca_system_score_gemma":0.000116797644,"threshold_uncertainty_score":0.4393536},"labels":[],"label_agreement":null},{"id":"W4237872600","doi":"10.1358/dot.2017.53.1.2604171","title":"Notable deals in the pharmaceutical industry in the fourth quarterof 2016","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.027553480783548294,"score_gpt":0.33860766792118985,"score_spread":0.31105418713764155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237872600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7466332,0.00062028057,0.0000061680867,0.22694466,0.00017710398,0.00024490015,0.0000019951954,0.000011325378,0.025360398],"genre_scores_gemma":[0.997116,0.00041829885,0.000037447688,0.00157652,0.00005196242,0.000010883048,0.0000011124134,0.000004363114,0.00078341033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927944,0.00006970485,0.00018971945,0.00010869291,0.00013939576,0.00021301815],"domain_scores_gemma":[0.99918634,0.00017690704,0.00007614331,0.0005197908,0.000016446224,0.000024365625],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00090373424,0.00007250083,0.0001529161,0.000050608112,0.00013420895,0.000015210044,0.00043341477,0.0020441443,0.0000365047],"category_scores_gemma":[0.0001469532,0.000035583038,0.00004135727,0.00006524988,0.0002531946,0.00004781101,0.00003951803,0.003950439,0.000025474224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002116389,0.0033772755,0.28188384,0.00038623248,0.00051376724,0.0012965834,0.029532425,0.00001920264,0.015438599,0.09447638,0.22724201,0.3437173],"study_design_scores_gemma":[0.012680192,0.0007520116,0.40213966,0.0012272296,0.00024630895,0.00025166676,0.014437196,0.0008039097,0.040902488,0.0060124984,0.5200621,0.00048476478],"about_ca_topic_score_codex":0.000120911856,"about_ca_topic_score_gemma":0.00003952295,"teacher_disagreement_score":0.34323254,"about_ca_system_score_codex":0.000009907252,"about_ca_system_score_gemma":0.00004423545,"threshold_uncertainty_score":0.9992514},"labels":[],"label_agreement":null},{"id":"W4246551118","doi":"10.1358/dot.2015.051.06.2339112","title":"American Psychiatric Association - 168th Annual Meeting (May 16-20, 2015 - Toronto, Canada)","year":2015,"lang":"en","type":"article","venue":"Drugs of today","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Association (psychology); Psychiatry; Family medicine; Environmental health","score_opus":0.006765480933943373,"score_gpt":0.26065377439794957,"score_spread":0.2538882934640062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246551118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61901057,0.025889268,0.000038245875,0.020621581,0.0016442164,0.0008009926,0.00044579958,0.00015031814,0.331399],"genre_scores_gemma":[0.9949873,0.000084600186,0.0005862041,0.0002678875,0.0001787949,0.00000844795,0.000082200204,0.000019422167,0.0037851483],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863625,0.000054509965,0.00024515245,0.00018224864,0.0006236547,0.00025816157],"domain_scores_gemma":[0.9990573,0.00004983133,0.00024188372,0.0002133177,0.00021762245,0.00022006033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029724694,0.00013437083,0.00031153386,0.000034541645,0.00004311117,0.0000063160105,0.00007800363,0.000044362143,0.000063814754],"category_scores_gemma":[0.000111958005,0.00011677063,0.00007050003,0.00014911086,0.000023191513,0.000082586004,0.000026800666,0.000089772104,0.0000098231285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106425396,0.00033469443,0.73148996,0.000031569616,0.0002691952,0.0000030545366,0.001577656,0.000008121021,0.000034231234,0.000099309545,0.2488675,0.017178303],"study_design_scores_gemma":[0.006962565,0.0013946432,0.33743164,0.00008331548,0.00088557316,0.000018007595,0.020800415,0.00008873611,0.0014528532,0.00021064117,0.6300816,0.0005900341],"about_ca_topic_score_codex":0.7030875,"about_ca_topic_score_gemma":0.7984918,"teacher_disagreement_score":0.39405832,"about_ca_system_score_codex":0.0013449952,"about_ca_system_score_gemma":0.0007216897,"threshold_uncertainty_score":0.4761768},"labels":[],"label_agreement":null},{"id":"W4247070633","doi":"10.1358/dot.2016.52.8.2540100","title":"Notable deals in the pharmaceutical industry in the first quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Competitive and Knowledge Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Milestone; Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.028297717841431168,"score_gpt":0.28253825327545823,"score_spread":0.2542405354340271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247070633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82484585,0.0004681723,0.00006671443,0.032025054,0.0004050803,0.0003613979,0.0000036241725,0.000020539006,0.14180355],"genre_scores_gemma":[0.9973326,0.00004518215,0.0000035726002,0.0016472241,0.00036796593,0.00002641854,7.336202e-7,0.00000646876,0.0005698611],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991085,0.000029476967,0.0002589881,0.0001471382,0.00019601318,0.0002598899],"domain_scores_gemma":[0.9990706,0.0005570181,0.000079487174,0.0002228223,0.00006450803,0.000005599211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010250685,0.00009935151,0.0001188242,0.00009494291,0.00008078974,0.000078947196,0.00057368114,0.000090466805,0.00024219918],"category_scores_gemma":[0.00014060552,0.000046291952,0.000047549063,0.0003058976,0.000092764545,0.00033147854,0.00008316169,0.0002598656,0.00042125996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027794234,0.0010959415,0.3866067,0.00028514036,0.00004207373,0.00006942058,0.004155207,0.000009188727,0.0016503509,0.20803447,0.13557005,0.2622035],"study_design_scores_gemma":[0.00054788665,0.000011610272,0.03759213,0.00031945703,0.000011104991,0.0000010896271,0.002105392,0.00013310331,0.0009810006,0.0046495018,0.9534948,0.00015295765],"about_ca_topic_score_codex":0.00028293417,"about_ca_topic_score_gemma":0.00072166265,"teacher_disagreement_score":0.81792474,"about_ca_system_score_codex":0.000016941927,"about_ca_system_score_gemma":0.000016396638,"threshold_uncertainty_score":0.5414585},"labels":[],"label_agreement":null},{"id":"W4247809272","doi":"10.1358/dot.2018.54.2.2792548","title":"Life sciences licensing deals in the fourthquarter of 2017: updatesand trends","year":2018,"lang":"en","type":"article","venue":"Drugs of today","topic":"Academic Publishing and Open Access","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Finance; Business","score_opus":0.10230217279665785,"score_gpt":0.4182660856357171,"score_spread":0.3159639128390592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247809272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88639665,0.00023754688,0.00009927287,0.012191847,0.0003551605,0.000062939056,0.000009484804,0.000007847228,0.10063924],"genre_scores_gemma":[0.9974926,0.000010598368,0.00046133925,0.0012471797,0.00018473205,0.0000015767863,0.0000010007993,0.000003790342,0.00059715856],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9967984,0.00031954967,0.000754791,0.00034675954,0.0015089655,0.00027155675],"domain_scores_gemma":[0.9970145,0.0016278066,0.00050599116,0.00050079724,0.00026432073,0.00008655857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011917074,0.000103546794,0.0003076567,0.00050182577,0.00016860366,0.00029441802,0.0030899965,0.000094881514,0.00032992815],"category_scores_gemma":[0.004629947,0.000055544504,0.00008395752,0.0018041362,0.00080173305,0.0012759182,0.00020760315,0.00018507296,0.000056331144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005270515,0.00009229163,0.059046883,0.0000053115323,0.000014492063,0.0000020063512,0.020432418,0.000044842523,0.00058326556,0.003946337,0.7813165,0.13446292],"study_design_scores_gemma":[0.0028814652,0.00091529946,0.4084908,0.00044211972,0.00007062297,0.00003486133,0.0665488,0.009196969,0.025187483,0.08281204,0.40232912,0.0010904042],"about_ca_topic_score_codex":0.00028731435,"about_ca_topic_score_gemma":0.000060970826,"teacher_disagreement_score":0.3789874,"about_ca_system_score_codex":0.000007635166,"about_ca_system_score_gemma":0.00014387892,"threshold_uncertainty_score":0.5742034},"labels":[],"label_agreement":null},{"id":"W4252160329","doi":"10.1358/dot.2017.53.10.2746403","title":"Notable licensing deals in the biopharma industry in the thirdquarter of 2017","year":2017,"lang":"en","type":"article","venue":"Drugs of today","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Mergers and acquisitions; Pharmaceutical industry; Pharmacology; Finance; Business","score_opus":0.0631181787243877,"score_gpt":0.3970966101145358,"score_spread":0.3339784313901481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252160329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94726765,0.000251919,0.000001118323,0.016519466,0.0001140333,0.00031588142,0.0000023898417,0.0000030138483,0.03552454],"genre_scores_gemma":[0.9977428,0.000081222606,0.000042499345,0.0014587963,0.00014454428,0.0000069021694,0.0000013719655,0.0000046324562,0.0005172407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986076,0.00009740219,0.00026069648,0.00014603553,0.0006095425,0.00027874034],"domain_scores_gemma":[0.99870044,0.00025185064,0.00014998516,0.0007589719,0.00008343786,0.000055316505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003107735,0.000080749145,0.00024745415,0.00014477398,0.00010233746,0.000023209292,0.0006447915,0.00013360019,0.000051239196],"category_scores_gemma":[0.0006065512,0.000039566265,0.0000475106,0.00018336454,0.0004161592,0.00012625742,0.000056321325,0.00067815004,0.00000919076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007140932,0.0014330925,0.5514231,0.0006198331,0.00007127344,0.0005163412,0.14003295,0.000012795448,0.15298809,0.001372498,0.07196773,0.07884825],"study_design_scores_gemma":[0.0032760596,0.00025982218,0.938185,0.0007695485,0.000037118327,0.000052063773,0.021495314,0.00023383759,0.027171396,0.0002141565,0.008205162,0.000100539604],"about_ca_topic_score_codex":0.0014924401,"about_ca_topic_score_gemma":0.00008193193,"teacher_disagreement_score":0.38676193,"about_ca_system_score_codex":0.000016045262,"about_ca_system_score_gemma":0.0001313268,"threshold_uncertainty_score":0.29462624},"labels":[],"label_agreement":null},{"id":"W4253026915","doi":"10.1358/dot.2003.39.4.799404","title":"Aminoglycoside ototoxicity","year":2003,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Aminoglycoside; Ototoxicity; Medicine; Pharmacology; Toxicity; Antibiotics; Gentamicin; Hearing loss; Internal medicine; Genetics; Biology; Audiology; Chemotherapy","score_opus":0.09214801784366826,"score_gpt":0.3536444778535877,"score_spread":0.26149646000991944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253026915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025449877,0.96393126,0.000035739344,0.000018615116,0.00075589237,0.0011081456,0.00010096885,0.000101314625,0.033693563],"genre_scores_gemma":[0.00020678036,0.9930875,0.0006105017,0.00029539646,0.00013615603,0.000058420566,0.000007891877,0.00011920385,0.005478208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961383,0.00055779674,0.0010633068,0.0009072672,0.0006879278,0.0006454253],"domain_scores_gemma":[0.997068,0.0006421973,0.00073278614,0.0012710233,0.000066236425,0.00021976058],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052112096,0.000576473,0.0017720279,0.00029918813,0.00010652518,0.000056489895,0.0011095867,0.00044562877,0.00025871873],"category_scores_gemma":[0.0013862662,0.00052669516,0.00061717955,0.0006662756,0.00024787095,0.00007418994,0.0003208298,0.0007007747,0.00080515037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003885192,0.00019748053,0.0000052105897,0.012600126,0.000029543602,0.000048610294,0.00020272183,0.0000039598744,0.000875934,0.0012198731,0.005073914,0.9797387],"study_design_scores_gemma":[0.00011225446,0.000044198998,0.0000020999173,0.0027846866,0.00014059266,0.00004353932,0.000005539004,0.0000034300863,0.010165408,0.00008412843,0.98615223,0.00046189054],"about_ca_topic_score_codex":0.000025533735,"about_ca_topic_score_gemma":0.000002228341,"teacher_disagreement_score":0.9810783,"about_ca_system_score_codex":0.00013607704,"about_ca_system_score_gemma":0.00045810026,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W4253652799","doi":"10.1358/dot.2011.47.10.1656503","title":"Boceprevir","year":2011,"lang":"en","type":"review","venue":"Drugs of today","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boceprevir; Medicine; Ribavirin; Pharmacology; Hepatitis C virus; Telaprevir; Virology; Internal medicine; Virus","score_opus":0.12138981915520225,"score_gpt":0.41693319128266637,"score_spread":0.2955433721274641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253652799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000023297134,0.83873993,0.0000022759261,0.00002328427,0.000107515996,0.0007593662,0.000052674648,0.000032760556,0.16027986],"genre_scores_gemma":[0.000011640298,0.99029964,0.0003162515,0.000039892322,0.00018831181,0.00007631941,0.00009419634,0.00007771733,0.008896001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817926,0.0001392341,0.000636491,0.0003289172,0.00039596992,0.00032011128],"domain_scores_gemma":[0.9984456,0.00013934264,0.00023309745,0.0008425184,0.00012942807,0.00021004176],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004595811,0.00027727845,0.002101272,0.000308432,0.000021062217,0.000006745262,0.0003400759,0.00032729656,0.0025253526],"category_scores_gemma":[0.00030888678,0.00020446595,0.000666109,0.00028750062,0.00011653985,0.000040004707,0.00016462608,0.00055518333,0.001994516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004760956,0.00006188888,0.000013399588,0.030302426,0.00015873785,0.000022187709,0.000074167736,9.68015e-10,3.0457866e-7,0.00021811239,0.010067927,0.9590761],"study_design_scores_gemma":[0.00016213059,0.00008619216,0.000004584395,0.018008301,0.00049918634,0.000013210881,0.0000037532782,3.0013868e-7,0.000010167904,0.000019587944,0.9810429,0.00014968059],"about_ca_topic_score_codex":0.0001186012,"about_ca_topic_score_gemma":0.0000019459703,"teacher_disagreement_score":0.970975,"about_ca_system_score_codex":0.00009063119,"about_ca_system_score_gemma":0.0005887087,"threshold_uncertainty_score":0.9987826},"labels":[],"label_agreement":null},{"id":"W4253960987","doi":"10.1358/dot.2016.52.10.2560079","title":"Notable deals in the pharmaceutical industry in the third quarterof 2016","year":2016,"lang":"en","type":"article","venue":"Drugs of today","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Pharmaceutical industry; Pharmacology","score_opus":0.01796769573493584,"score_gpt":0.30438071112821696,"score_spread":0.2864130153932811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253960987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6813842,0.00088813,0.0000131737925,0.30086347,0.00014185726,0.00024507332,0.0000026792825,0.000019131983,0.016442241],"genre_scores_gemma":[0.9955125,0.0006455158,0.000020598438,0.0025079367,0.000044292254,0.000013916565,6.6788e-7,0.000004619735,0.0012499604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916,0.00010633579,0.0002297679,0.00011795657,0.0001525227,0.00023340598],"domain_scores_gemma":[0.9991988,0.00041999074,0.00004465055,0.00029335817,0.0000177911,0.000025413881],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0009216644,0.00007706446,0.00015144522,0.00006911275,0.00003933836,0.0000040673726,0.0002513231,0.0022164753,0.00006275545],"category_scores_gemma":[0.0001048194,0.000029521423,0.00004217872,0.00017727731,0.0002048697,0.00003817807,0.000024906167,0.002657135,0.000054476495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019518505,0.0025244108,0.105204456,0.00021636368,0.000345014,0.00056374416,0.018322354,0.0000028137476,0.085233666,0.10253339,0.3421437,0.3409582],"study_design_scores_gemma":[0.013427928,0.0008623006,0.10225151,0.0018506275,0.0001876002,0.00025745694,0.011962779,0.00008366925,0.12544991,0.0079165185,0.7352756,0.0004740708],"about_ca_topic_score_codex":0.00004113596,"about_ca_topic_score_gemma":0.000015740407,"teacher_disagreement_score":0.3931319,"about_ca_system_score_codex":0.000015650568,"about_ca_system_score_gemma":0.000047176436,"threshold_uncertainty_score":0.9996438},"labels":[],"label_agreement":null},{"id":"W4282918298","doi":"10.1358/dot.2022.58.6.3400572","title":"Bimekizumab for psoriasis","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secukinumab; Psoriasis; Ustekinumab; Tolerability; Adalimumab; Adverse effect; Dermatology; Immunology; Immune system; Population; Internal medicine; Tumor necrosis factor alpha; Psoriatic arthritis","score_opus":0.01460619210585043,"score_gpt":0.24055590479578004,"score_spread":0.2259497126899296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282918298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842106,0.004532663,0.00007271987,0.0006333242,0.0029047655,0.00052008004,0.000884968,0.00008648548,0.0061543854],"genre_scores_gemma":[0.98905003,0.000025149442,0.00024911162,0.00008338087,0.00003802028,0.0002419412,0.00028622747,0.00001543768,0.010010702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928176,0.00009855236,0.00018612458,0.00018969645,0.00003355436,0.00021028315],"domain_scores_gemma":[0.99945295,0.0001792435,0.00010134567,0.00022259801,0.000032944652,0.000010900402],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021383252,0.000105915235,0.00021596975,0.00009287397,0.0002504033,0.0000026599857,0.00020901019,0.000062259285,0.0016412139],"category_scores_gemma":[0.000025621372,0.00009942431,0.0001739207,0.000108000866,0.000043752294,0.000029928851,0.000090453075,0.00006765816,0.000076155615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027677051,0.001249591,0.0024915235,0.00008403315,0.0018227312,0.000006441995,0.0053352285,0.000074045034,0.23848842,0.014563572,0.12641488,0.60670185],"study_design_scores_gemma":[0.0050167744,0.0006074563,0.0017546918,0.000006671706,0.00025366378,0.000018205643,0.0012801595,0.000003923407,0.27484968,0.0011558349,0.7148029,0.0002500268],"about_ca_topic_score_codex":0.000048148533,"about_ca_topic_score_gemma":0.0000023469102,"teacher_disagreement_score":0.6064518,"about_ca_system_score_codex":0.000036198602,"about_ca_system_score_gemma":0.000041432486,"threshold_uncertainty_score":0.9992714},"labels":[],"label_agreement":null},{"id":"W4294577824","doi":"10.1358/dot.2022.58.9.3422313","title":"Efficacy of vosoritide in the treatment of achondroplasia","year":2022,"lang":"en","type":"article","venue":"Drugs of today","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Achondroplasia; Medicine; Endocrinology; Natriuretic peptide; Internal medicine; Dwarfism; Mutation; NPR2; Fibroblast growth factor receptor 3; Guanosine; Mutant; Receptor; Genetics; Fibroblast growth factor; Gene; Biology; Surgery","score_opus":0.013059932695318027,"score_gpt":0.2960372429706298,"score_spread":0.28297731027531176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294577824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963133,0.0013368335,0.0000053185854,0.00020841113,0.00002459245,0.00022563938,0.00003959667,8.7574153e-7,0.0018454498],"genre_scores_gemma":[0.99942863,0.00013630306,0.000029408904,0.00001061747,0.000012511801,0.0000402309,0.00004193751,0.0000061912115,0.00029417872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993219,0.00013345016,0.0001498099,0.00012441602,0.00016991752,0.000100534926],"domain_scores_gemma":[0.99955547,0.000065383196,0.000058960406,0.00027224698,0.000036237056,0.0000116759475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001583913,0.000057033663,0.00012318623,0.000050241324,0.000022157139,0.0000011636795,0.0002151997,0.000021118398,0.00007339927],"category_scores_gemma":[0.00005636307,0.000045535733,0.00008030463,0.00012665067,0.00006386908,8.194031e-7,0.00006295352,0.00003891765,6.323788e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007980052,0.0029009196,0.03814626,0.00005536017,0.00013688869,0.000007413325,0.0063084536,0.0004678903,0.9152518,0.0004895922,0.0010988617,0.034338582],"study_design_scores_gemma":[0.0036459318,0.0034230943,0.06376454,0.000010021929,0.000022427534,0.000005565353,0.005150767,0.000032002437,0.8636045,0.00015862263,0.060047317,0.00013524444],"about_ca_topic_score_codex":0.00021647153,"about_ca_topic_score_gemma":0.000044691074,"teacher_disagreement_score":0.058948454,"about_ca_system_score_codex":0.000014460033,"about_ca_system_score_gemma":0.000046414898,"threshold_uncertainty_score":0.18568933},"labels":[],"label_agreement":null},{"id":"W4322495836","doi":"10.1358/dot.2023.59.3.3521858","title":"Cenegermin for the treatment of dry eye disease","year":2023,"lang":"en","type":"review","venue":"Drugs of today","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Tropomyosin receptor kinase A; Nerve growth factor; Clinical trial; Disease; Authorization; Intensive care medicine; Ophthalmology; Internal medicine; Receptor","score_opus":0.05328641506398813,"score_gpt":0.3666833527670074,"score_spread":0.3133969377030193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322495836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025255556,0.9969336,0.000007970359,0.000189061,0.00022586611,0.0017975069,0.00038804568,0.000022287652,0.0001831105],"genre_scores_gemma":[0.00007606475,0.989126,0.000057934198,0.000019783838,0.00016902525,0.00023858211,0.00017065222,0.000054253123,0.010087705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989761,0.00003645663,0.00042292138,0.00020230871,0.00019165924,0.0001705229],"domain_scores_gemma":[0.99849844,0.0004592701,0.00025177049,0.00063454517,0.00006207611,0.00009389441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012504008,0.00023187569,0.001317175,0.000076168115,0.000028575869,0.0000036654062,0.00013393104,0.00010012904,0.000032486358],"category_scores_gemma":[0.000056330333,0.00012307367,0.0012245512,0.00013120654,0.00004302991,0.00001251298,0.000020559219,0.000059011763,0.000038797472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004444543,0.00023345352,0.00026611696,0.019337932,0.0007754045,0.0000133229705,0.00015108903,3.3544725e-7,7.1970965e-7,0.00011420124,0.000079303856,0.9789837],"study_design_scores_gemma":[0.00047046624,0.00022201789,0.00022728156,0.0068075564,0.0050350097,4.4224883e-8,0.00005479997,0.0000061428445,0.000022472279,0.000019481991,0.9870344,0.00010034532],"about_ca_topic_score_codex":0.000046968064,"about_ca_topic_score_gemma":0.0000043951095,"teacher_disagreement_score":0.9869551,"about_ca_system_score_codex":0.00006354312,"about_ca_system_score_gemma":0.00032987288,"threshold_uncertainty_score":0.5018799},"labels":[],"label_agreement":null}]}